


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:03:39Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12408086" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12408086</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>reben</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Enferm</journal-id><journal-id journal-id-type="iso-abbrev">Rev Bras Enferm</journal-id><journal-id journal-id-type="pmc-domain-id">4332</journal-id><journal-id journal-id-type="pmc-domain">reben</journal-id><journal-id journal-id-type="publisher-id">reben</journal-id><journal-title-group><journal-title>Revista Brasileira de Enfermagem</journal-title></journal-title-group><issn pub-type="ppub">0034-7167</issn><issn pub-type="epub">1984-0446</issn><publisher><publisher-name>Associa&#231;&#227;o Brasileira de Enfermagem</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12408086</article-id><article-id pub-id-type="pmcid-ver">PMC12408086.1</article-id><article-id pub-id-type="pmcaid">12408086</article-id><article-id pub-id-type="pmcaiid">12408086</article-id><article-id pub-id-type="pmid">40900564</article-id><article-id pub-id-type="doi">10.1590/0034-7167-2024-0346</article-id><article-id pub-id-type="other">00173</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>International Pain Outcomes (IPO) &#8211; Brazilian Portuguese version: cross-cultural adaptation and psychometric validation</article-title><trans-title-group xml:lang="es"><trans-title>International Pain Outcomes (IPO) &#8211; versi&#243;n en portugu&#233;s de Brasil: adaptaci&#243;n transcultural y validaci&#243;n psicom&#233;trica</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8431-6712</contrib-id><name name-style="western"><surname>Felix</surname><given-names initials="MMDS">Marcia Marques dos Santos</given-names></name><role>conception or design of the study/research</role><role>analysis and/or interpretation of data</role><xref rid="aff1" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1591-2542</contrib-id><name name-style="western"><surname>Tibola</surname><given-names initials="TSA">Talita Silva Alves</given-names></name><role>conception or design of the study/research</role><role>analysis and/or interpretation of data</role><xref rid="aff1" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4487-9232</contrib-id><name name-style="western"><surname>Raponi</surname><given-names initials="MBG">Maria Beatriz Guimar&#227;es</given-names></name><role>conception or design of the study/research</role><role>analysis and/or interpretation of data</role><xref rid="aff2" ref-type="aff">II</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1984-0486</contrib-id><name name-style="western"><surname>da Silva</surname><given-names initials="ACR">Ana C&#237;ntia Ribeiro</given-names></name><role>analysis and/or interpretation of data</role><xref rid="aff1" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0724-8124</contrib-id><name name-style="western"><surname>Calegari</surname><given-names initials="IB">Isadora Braga</given-names></name><role>analysis and/or interpretation of data</role><xref rid="aff1" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7923-8497</contrib-id><name name-style="western"><surname>de Faria</surname><given-names initials="MF">Ma&#237;la Fidalgo</given-names></name><role>analysis and/or interpretation of data</role><xref rid="aff1" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2537-3909</contrib-id><name name-style="western"><surname>Pires</surname><given-names initials="PDS">Patr&#237;cia da Silva</given-names></name><role>final review with critical and intellectual participation in the manuscript</role><xref rid="aff3" ref-type="aff">III</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2749-2802</contrib-id><name name-style="western"><surname>Barbosa</surname><given-names initials="MH">Maria Helena</given-names></name><role>conception or design of the study/research</role><role>analysis and/or interpretation of data</role><role>final review with critical and intellectual participation in the manuscript</role><xref rid="aff1" ref-type="aff">I</xref></contrib></contrib-group><aff id="aff1">
<label>I</label>Universidade Federal do Tri&#226;ngulo Mineiro. Uberaba, Minas Gerais, Brazil</aff><aff id="aff2">
<label>II</label>Universidade Federal de Uberl&#226;ndia. Uberl&#226;ndia, Minas Gerais, Brazil</aff><aff id="aff3">
<label>III</label>Universidade Federal da Bahia. Vit&#243;ria da Conquista, Bahia, Brazil</aff><author-notes><corresp id="c1"><label>Corresponding author</label> Maria Helena Barbosa, E-mail: <email>mhelena331@hotmail.com</email></corresp><fn fn-type="edited-by"><p><bold>EDITOR IN CHIEF:</bold> Antonio Jos&#233; de Almeida Filho</p></fn><fn fn-type="edited-by"><p><bold>ASSOCIATE EDITOR:</bold> Hugo Fernandes</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>78</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">481287</issue-id><elocation-id>e20240346</elocation-id><history><date date-type="received"><day>13</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>07</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 17:25:14.637"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="0034-7167-reben-78-03-e20240346.pdf"/><abstract><title>ABSTRACT</title><sec><title>Objectives:</title><p>to adapt the International Pain Outcomes questionnaire into Brazilian Portuguese and evaluate its clinimetric properties.</p></sec><sec><title>Methods:</title><p>we conducted a methodological, quantitative, validation, and cross-cultural adaptation study of the instrument. The process included translation, synthesis, expert committee review, back-translation, consensus between the English versions and comparison with the original version, pretest phase (n=30), and metric property validation (convergent validity, n=360; interobserver reliability analysis, n=54; internal consistency, n=360).</p></sec><sec><title>Results:</title><p>the cross-cultural adaptation was successfully performed, and the instrument was considered valid in terms of adequacy and applicability. In the convergent validity analysis, all correlations showed p&#8804;0.001. Cronbach&#8217;s alpha was 0.796, Kappa was 1.0 (for dichotomous items), and the Intraclass Correlation Coefficient was &gt;0.999 (for quantitative items).</p></sec><sec><title>Conclusions:</title><p>the instrument was deemed adequate for cultural adaptation, validated for Brazilian Portuguese, and reliable for application in the care of postoperative patients.</p></sec></abstract><trans-abstract xml:lang="es"><title>RESUMEN</title><sec><title>Objetivos:</title><p>adaptar al portugu&#233;s de Brasil y evaluar las propiedades clinim&#233;tricas del cuestionario <italic toggle="yes">International Pain Outcomes</italic>.</p></sec><sec><title>M&#233;todos:</title><p>estudio metodol&#243;gico, cuantitativo, de validaci&#243;n y adaptaci&#243;n transcultural de un instrumento. Se realizaron las siguientes etapas: traducci&#243;n, s&#237;ntesis, evaluaci&#243;n por un Comit&#233; de Expertos, retrotraducci&#243;n, consenso de las versiones en ingl&#233;s y comparaci&#243;n con la versi&#243;n original, pretest (n=30) y validaci&#243;n psicom&#233;trica (validez convergente, n=360; confiabilidad entre observadores, n=54; consistencia interna, n=360).</p></sec><sec><title>Resultados:</title><p>la adaptaci&#243;n transcultural se realiz&#243; satisfactoriamente, consider&#225;ndose el instrumento v&#225;lido en cuanto a adecuaci&#243;n y aplicabilidad. En la validez convergente, todas las correlaciones presentaron p&#8804;0,001. Se obtuvo un alfa de Cronbach de 0,796, Kappa=1,0 (&#237;tems dicot&#243;micos) y un coeficiente de correlaci&#243;n intraclase &gt; 0,999 (&#237;tems cuantitativos).</p></sec><sec><title>Conclusiones:</title><p>se consider&#243; el instrumento adecuado en t&#233;rminos de adaptaci&#243;n cultural, validado para el portugu&#233;s de Brasil y confiable para su aplicaci&#243;n en la atenci&#243;n a pacientes en postoperatorio.</p></sec></trans-abstract><kwd-group><title>Descriptors:</title><kwd>Pain, Postoperative</kwd><kwd>Pain Management</kwd><kwd>Nursing Methodology Research</kwd><kwd>Validation Study</kwd><kwd>Psychometrics</kwd></kwd-group><kwd-group xml:lang="es"><title>Descriptores:</title><kwd>Dolor Postoperatorio</kwd><kwd>Manejo del Dolor</kwd><kwd>Investigaci&#243;n Metodol&#243;gica en Enfermer&#237;a</kwd><kwd>Estudio de Validaci&#243;n</kwd><kwd>Psicometr&#237;a</kwd></kwd-group><funding-group><award-group><funding-source>CAPES</funding-source><award-id>FAPEMIG/PPM-APQ-00121-17</award-id></award-group><funding-statement> This study was supported by the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) and the Minas Gerais Research Support Foundation (FAPEMIG/PPM-APQ-00121-17). </funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Postoperative pain is a physiological response to tissue damage caused by surgical procedures, leading to an unpleasant physical and psychological experience<sup>(<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>)</sup>. A significant number of patients experience this type of pain despite numerous evidence-based guidelines and protocols, targeted clinical interventions, and standardized assessments<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>. It is estimated that 240 million patients undergo surgical procedures each year, with 40% to 60% reporting clinically significant pain<sup>(<xref rid="B5" ref-type="bibr">5</xref>-<xref rid="B8" ref-type="bibr">8</xref>)</sup>.</p><p>When inadequately managed, postoperative pain can increase the risk of respiratory and cardiovascular complications, resulting in higher healthcare costs and negatively affecting surgical outcomes and patient satisfaction. It can also lead to postoperative complications that, if unresolved, may increase morbidity and mortality and contribute to disabling chronic pain<sup>(<xref rid="B9" ref-type="bibr">9</xref>-<xref rid="B11" ref-type="bibr">11</xref>)</sup>. Proper pain management not only provides relief but also facilitates faster patient recovery<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</sup>.</p><p>To ensure effective pain management, healthcare professionals must assess pain incidence, its intensity at rest and during daily activities (such as walking, turning in bed, and falling asleep), verify analgesic protocols, monitor adverse effects of medications, evaluate emotional states (such as anxiety, anger, and fear), and assess patient satisfaction, while also incorporating holistic care approaches to pain management<sup>(<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>To support healthcare professionals in optimizing postoperative pain management in Europe, the PAIN OUT project&#8212;an international initiative funded by the European Commission<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup> in partnership with the American Pain Society&#8212;developed the International Pain Outcomes (IPO) questionnaire. This instrument assesses variability in patient care, identifies best practices in pain management, and helps healthcare providers in decision-making<sup>(<xref rid="B17" ref-type="bibr">17</xref>)</sup>.</p><p>The IPO questionnaire was designed to evaluate the quality of postoperative pain treatment during the first 24 hours of hospital care and was specifically adapted for the postoperative setting. The most recent English version was revised and validated in 2010<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup>, and its psychometric properties were assessed in 2013<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>.</p><p>The cross-cultural adaptation of the IPO to the Brazilian context and the evaluation of its metric properties will enable the availability of an instrument to assist healthcare professionals in assessing pain intensity, severity, and patients&#8217; functional ability after surgery. These applications will contribute to effective postoperative pain management, consequently improving the quality of care, enhancing patient safety, and reducing operational costs for healthcare institutions.</p></sec><sec><title>OBJECTIVES</title><p>To adapt the International Pain Outcomes (IPO) questionnaire into Brazilian Portuguese and evaluate its clinimetric properties.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Ethical aspects</title><p>This study followed the recommendations of Resolution 466/2012 of the Brazilian National Health Council. The Research Ethics Committee of the host institution approved it. All participants received verbal and written information about the study objectives and signed the Informed Consent Form (ICF).</p></sec><sec><title>Study design, period, and location</title><p>This methodological and quantitative study was conducted in two phases: cross-cultural adaptation and psychometric validation. We carried out it in the Surgical Clinic Unit of a large teaching hospital in the state of Minas Gerais (MG), Brazil. Data collection took place from October to November 2022 (pretest phase) and from February to August 2023 (psychometric validation).</p></sec><sec><title>Population, sample, inclusion, and exclusion criteria</title><p>The population involved in the cross-cultural adaptation phase consisted of PhD-level expert judges specializing in the study&#8217;s subject and methodology. For the pretest phase and psychometric validation phases, the target population comprised postoperative patients hospitalized in the Surgical Clinic Unit of the host institution.</p><p>For the sample size calculation of convergent validity, the required sample was determined based on an expected minimum correlation of 0.2 between the IPO and the Brief Pain Inventory (BPI)<sup>(<xref rid="B19" ref-type="bibr">19</xref>)</sup>, with a 95% statistical power and a significance level (alpha) of 0.005. With these parameters, the Power Analysis &amp; Sample Size (PASS) software, version 15, defined the minimum required sample size of 319 participants. However, the final sample included 360 participants.</p><p>The sample size calculation for interobserver reliability analysis was based on an expected Intraclass Correlation Coefficient (ICC) of 0.8 between the items of the adapted IPO version, assuming that it would not fall below 0.6, with a 90% statistical power and an alpha of 0.05. Using these parameters in PASS, version 13, the minimum required sample size was 54 patients.</p><p>The inclusion criteria for the expert judges were: being Brazilian, having expertise in the study&#8217;s subject or methodology, and being clinical nurses directly involved in patient care, all holding a minimum academic degree of PhD and proficiency in English. The judges&#8217; academic credentials were verified through their Lattes Curriculum. Experts who did not return the completed questionnaires within 30 days were considered lost to sample attrition.</p><p>The study included patients aged 18 years or older who had undergone elective or emergency surgery, were hospitalized in the Surgical Clinic Unit of the host institution during the data collection period, had been postoperative for at least 24 hours, and were conscious enough to respond to the questionnaire.</p><p>Patients unable to engage in dialogue with the researcher were excluded from the study.</p></sec><sec><title>Study protocol</title><p>We conducted this study after receiving approval from Dr. Claudia Weinmann, the PAIN OUT project administrator. On April 23, 2018, she granted authorization via email for the instrument to undergo the cross-cultural adaptation process into Brazilian Portuguese.</p><p>The IPO questionnaire consists of 18 primary items and 3 secondary items. The primary items assess pain intensity, duration of severe pain, the impact of pain on physical activity, sleep, and emotional state, adverse side effects of treatment, perceived pain relief, level of participation in treatment, and satisfaction with pain management. The secondary items evaluate both the use of non pharmacological approaches for pain relief and the perceived usefulness of information received during treatment. Except for the items measuring duration of severe pain and the extent of pain relief received, which are anchored on a 0% to 100% scale, all primary IPO items are assessed using a numeric rating scale (NRS) ranging from 0 to 10<sup>(<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B18" ref-type="bibr">18</xref>)</sup>.</p><p>For the cross-cultural adaptation and validation of the instrument, we followed the guidelines proposed by Ferrer et al. (1996)<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup> and Beaton et al. (2007)<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>Two Brazilian translators fluent in English independently translated the instrument. One of them had expertise in the study&#8217;s subject matter. The researchers compared both translations, and any discrepancies or ambiguities were clarified with the translators. After analyzing the versions, we synthesized the translations, reaching the first consensus version in Portuguese.</p><p>Next, an expert committee of 11 judges evaluated the Portuguese version. This panel included two translators, one postdoctoral researcher in healthcare, five PhD-level nursing professors specializing in the study&#8217;s subject and methodology from public universities, and three clinical nurses with PhDs who worked directly in patient care. All had proficiency in English and experience with the study&#8217;s topic. Their goal was to assess semantic, idiomatic, cultural, and conceptual equivalences of the items, as well as face and content validity.</p><p>We invited the judges via email, which included an invitation letter and the Informed Consent Form (ICF) detailing the purpose and objectives of the study. Those who agreed to participate were required to sign the ICF, scan it, and email it back to us. After receiving their consent, we sent a second email containing both the original English version and the translated Portuguese version for instrument evaluation. The judges then returned the evaluated instrument to us via email.</p><p>After all judges returned the evaluated instruments, we assessed content validity through a consensus meeting held via Google Meet with the study authors, the research team, and the expert committee. The judges requested that the original layout be maintained and suggested modifications to the translation. All proposed changes were incorporated, resulting in the Portuguese Consensus Version 1 (PCV1).</p><p>We then back-translated PCV1 from Portuguese to English. Two independent translators, native English speakers proficient in Portuguese, conducted the back-translation. They were unfamiliar with the original instrument and had not participated in the initial translation phase. As a result, two new English versions were produced. We compared these versions and synthesized them into a final back-translated version, which was sent to the authors of the original instrument for evaluation.</p><p>The document was returned without any modifications, confirming the accuracy of the translation. This step resulted in the Portuguese Pre-Final Version of the IPO, which was then subjected to a pretest. For this phase, we selected a non-probabilistic sample of 30 patients, following the recommendations of the methodological framework adopted. The participants were 18 years or older, in the postoperative period of various surgeries, hospitalized in different surgical and recovery units of the host institution, and had been in the inpatient unit for at least 24 hours postoperatively.</p><p>Between October and November 2022, we collected data through self administration of the adapted IPO version and an instrument designed to gather demographic and clinical characterization data. During this phase, participants were encouraged to suggest improvements to the questionnaire whenever they deemed necessary.</p><p>Two evaluators assessed convergent validity through independent and simultaneous administration of the IPO and the Brief Pain Inventory (BPI). Data collection took place in the postoperative period (minimum of 24 hours) in a non-probabilistic sample of 360 patients. The empirical evidence for convergent validity was analyzed by examining correlations between conceptually similar items in both instruments (IPO and BPI).</p><p>The internal consistency of the items in the adapted version was assessed by calculating the Kuder-Richardson coefficient (KR-20) for dichotomous items and the original Cronbach&#8217;s alpha coefficient for quantitative items. Acceptable values ranged between 0.70 and 0.90<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup>.</p><p>To evaluate interobserver reliability, two researchers simultaneously administered the IPO questionnaire to 54 patients, maintaining physical distance from each other and avoiding any communication or exchange of information during data collection. The Kappa coefficient was used for dichotomous items, while the ICC was applied to quantitative items to determine the degree of agreement between the two observers.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Cross-cultural adaptation to Brazilian Portuguese</title><p>During the translation and synthesis phase, the discrepancies identified between the translations were related to words or terms with similar meanings in Brazilian Portuguese (e.g., surgery/surgical procedure; pain administration/pain management; provide/deliver).</p><p>In the expert committee review phase, the members proposed relevant modifications and improvements. After a Google Meet meeting with the study authors, research team, and expert committee members, all suggested changes were discussed, reviewed, and incorporated (<xref rid="t1" ref-type="table">Chart 1</xref>).</p><table-wrap position="float" id="t1" orientation="portrait"><label>Chart 1</label><caption><title>Description of modified items after the expert committee review compared to the translated version of the International Pain Outcomes questionnaire</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1">TRANSLATED VERSION</th><th align="left" colspan="2" rowspan="1">VERSION AFTER EXPERT COMMITTEE REVIEW</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">QUESTION&#193;RIO SOBRE OS RESULTADOS DO PACIENTE</td><td align="left" colspan="2" rowspan="1">QUESTION&#193;RIO SOBRE OS RESULTADOS DO PACIENTE</td></tr><tr><td align="left" colspan="2" rowspan="1">C&#211;DIGO DO PACIENTE:</td><td align="left" colspan="2" rowspan="1">C&#211;DIGO DO PACIENTE</td></tr><tr><td align="left" colspan="2" rowspan="1">Caro senhor/senhora<break/>Agradecemos se voc&#234; puder participar da nossa pesquisa sobre como os pacientes se sentem ap&#243;s uma cirurgia. O objetivo da pesquisa &#233; melhorar a administra&#231;&#227;o da dor ap&#243;s cirurgias neste departamento.<break/>Sua participa&#231;&#227;o &#233; volunt&#225;ria, e a informa&#231;&#227;o que voc&#234; proporcionar vai tornar-se an&#244;nima assim que voc&#234; entregar este question&#225;rio. Isso significa que seu nome e outras formas de identifica&#231;&#227;o ser&#227;o apagados do question&#225;rio ap&#243;s a entrega e n&#227;o ser&#227;o inclu&#237;dos em quaisquer registros mantidos por n&#243;s.<break/>Suas respostas neste question&#225;rio n&#227;o ser&#227;o compartilhadas com sua equipe m&#233;dica ou de enfermagem.<break/>Sua equipe vai trat&#225;-lo(a) da mesma forma se voc&#234; escolher participar ou n&#227;o da pesquisa.<break/>Muito obrigado por considerar participar desta pesquisa.</td><td align="left" colspan="2" rowspan="1">Caro(a) Senhor/Senhora<break/>N&#243;s ficar&#237;amos muito gratos pela sua participa&#231;&#227;o em nossa pesquisa sobre como os pacientes se sentem ap&#243;s um procedimento cir&#250;rgico. O objetivo desta pesquisa &#233; melhorar o tratamento da dor p&#243;s-operat&#243;ria nesta unidade.<break/>Sua participa&#231;&#227;o &#233; volunt&#225;ria, e as informa&#231;&#245;es que voc&#234; fornecer ser&#227;o armazenadas de forma an&#244;nima assim que voc&#234; entregar este question&#225;rio. Isso significa que seu nome e outras formas de identifica&#231;&#227;o ser&#227;o apagados do question&#225;rio ap&#243;s a entrega e n&#227;o ser&#227;o inclu&#237;dos em nenhum dos nossos registros.<break/>Suas respostas neste question&#225;rio n&#227;o ser&#227;o compartilhadas com sua equipe m&#233;dica ou de enfermagem.<break/>A equipe de profissionais que cuida de voc&#234; vai trat&#225;-lo(a) da mesma forma, independentemente se voc&#234; escolher participar ou n&#227;o da pesquisa.<break/>Muito obrigado por considerar participar desta pesquisa.</td></tr><tr><td align="left" colspan="2" rowspan="1">As quest&#245;es a seguir s&#227;o sobre a dor que voc&#234; sentiu desde a cirurgia.</td><td align="left" colspan="2" rowspan="1">As quest&#245;es a seguir s&#227;o sobre a dor que voc&#234; sentiu desde a cirurgia.</td></tr><tr><td align="left" colspan="2" rowspan="1">P1. Nesta escala, por favor indique a pior dor que voc&#234; teve desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P1. Nesta escala, por favor assinale o n&#250;mero que representa a pior dor que voc&#234; sentiu desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">P2. Nesta escala, por favor indique a dor menos intensa que voc&#234; teve desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P2. Nesta escala, por favor assinale o n&#250;mero que representa a dor menos intensa que voc&#234; sentiu desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">P3. Com que frequ&#234;ncia voc&#234; teve dor intensa desde a cirurgia?<break/>Por favor, circule sua melhor estimativa da porcentagem de tempo durante o qual voc&#234; teve dor intensa:</td><td align="left" colspan="2" rowspan="1">P3. Com que frequ&#234;ncia voc&#234; sentiu dor intensa desde a cirurgia?<break/>Por favor, assinale a porcentagem que mais se aproxima do tempo durante o qual voc&#234; sentiu dor intensa:</td></tr><tr><td align="left" rowspan="1" colspan="1">Nunca tive dor intensa</td><td align="left" rowspan="1" colspan="1">Dor intensa o tempo todo</td><td align="left" rowspan="1" colspan="1">Nunca senti dor intensa</td><td align="left" rowspan="1" colspan="1">Dor intensa o tempo todo</td></tr><tr><td align="left" colspan="2" rowspan="1">P4. Circule o n&#250;mero que melhor descreve o quanto, desde a cirurgia, a dor interferiu ou o(a) impediu de ...</td><td align="left" colspan="2" rowspan="1">P4. Assinale o n&#250;mero que melhor descreve o quanto, ap&#243;s a cirurgia, a dor interferiu ou o(a) impediu de...</td></tr><tr><td align="left" colspan="2" rowspan="1">a. fazer atividades na cama como virar, sentar, mudar de posi&#231;&#227;o:</td><td align="left" colspan="2" rowspan="1">a. realizar atividades na cama, tais como virar, sentar, mudar de posi&#231;&#227;o:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">b. respirar profundamente ou tossir:</td><td align="left" colspan="2" rowspan="1">b. respirar profundamente ou tossir:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">c. dormir:</td><td align="left" colspan="2" rowspan="1">c. dormir:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">d. Voc&#234; saiu da cama desde a cirurgia?</td><td align="left" colspan="2" rowspan="1">d. Voc&#234; conseguiu se levantar da cama ap&#243;s a cirurgia?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Se sim, quanto a dor o(a) atrapalhou ou impediu de fazer atividades fora da cama como caminhar, sentar-se em uma cadeira, ficar em p&#233; &#224; beira da pia:</td><td align="left" colspan="2" rowspan="1">Se sim, quanto a dor o(a) atrapalhou ou impediu de fazer atividades fora da cama, tais como caminhar, sentar-se em uma cadeira, ir ao banheiro:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">P5. A dor pode afetar o humor e as emo&#231;&#245;es.</td><td align="left" colspan="2" rowspan="1">P5. A dor pode influenciar o nosso humor e as nossas emo&#231;&#245;es.</td></tr><tr><td align="left" colspan="2" rowspan="1">Nesta escala, por favor circule o n&#250;mero que melhor mostra o quanto, desde a cirurgia, a dor fez com que voc&#234; se sentisse...</td><td align="left" colspan="2" rowspan="1">Nesta escala, por favor assinale o n&#250;mero que melhor descreve o quanto, ap&#243;s a sua cirurgia, a dor fez com que voc&#234; se sentisse...</td></tr><tr><td align="left" colspan="2" rowspan="1">a. ansioso(a)</td><td align="left" colspan="2" rowspan="1">a. ansioso(a)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td></tr><tr><td align="left" colspan="2" rowspan="1">b. incapaz</td><td align="left" colspan="2" rowspan="1">b. desamparado</td></tr><tr><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td></tr><tr><td align="left" colspan="2" rowspan="1">P6. Voc&#234; teve algum dos seguintes efeitos colaterais desde a cirurgia?</td><td align="left" colspan="2" rowspan="1">P6. Voc&#234; percebeu algum dos seguintes efeitos colaterais desde a cirurgia?</td></tr><tr><td align="left" colspan="2" rowspan="1">Por favor, circule &#8220;0&#8221; se n&#227;o teve; se teve, circule o n&#250;mero que melhor representa a intensidade de cada um:</td><td align="left" colspan="2" rowspan="1">Por favor, assinale &#8220;0&#8221; se n&#227;o sentiu; se sentiu, assinale o n&#250;mero que melhor representa a intensidade de cada um:</td></tr><tr><td align="left" colspan="2" rowspan="1">a. N&#225;usea</td><td align="left" colspan="2" rowspan="1">a. N&#225;usea</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">b. Sonol&#234;ncia</td><td align="left" colspan="2" rowspan="1">b. Sonol&#234;ncia</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">c. Coceira</td><td align="left" colspan="2" rowspan="1">c. Coceira</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">d. Tontura</td><td align="left" colspan="2" rowspan="1">d. Tonturas</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">P7. Desde a cirurgia, quanto al&#237;vio para a dor voc&#234; recebeu?</td><td align="left" colspan="2" rowspan="1">P7. Desde a cirurgia, quanto al&#237;vio para a dor voc&#234; sentiu?</td></tr><tr><td align="left" colspan="2" rowspan="1">Por favor, circule a porcentagem que melhor representa quanto al&#237;vio para dor voc&#234; recebeu de todos os tratamentos para dor juntos (tratamentos medicamentosos ou n&#227;o):</td><td align="left" colspan="2" rowspan="1">Por favor, assinale a porcentagem que melhor representa o n&#237;vel de al&#237;vio para dor sentido ap&#243;s todos os tratamentos para dor utilizados (tratamentos medicamentosos e n&#227;o medicamentosos):</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhum al&#237;vio</td><td align="left" rowspan="1" colspan="1">Al&#237;vio completo</td><td align="left" rowspan="1" colspan="1">Nenhum al&#237;vio</td><td align="left" rowspan="1" colspan="1">Al&#237;vio completo</td></tr><tr><td align="left" colspan="2" rowspan="1">P8. Voc&#234; gostaria de ter recebido MAIS tratamento para a dor do que recebeu?</td><td align="left" colspan="2" rowspan="1">P8. Voc&#234; gostaria de ter recebido MAIS tratamento para a dor do que recebeu?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">P9. Voc&#234; recebeu alguma informa&#231;&#227;o sobre suas op&#231;&#245;es de tratamento para a dor?</td><td align="left" colspan="2" rowspan="1">P9. Voc&#234; recebeu alguma informa&#231;&#227;o sobre as suas op&#231;&#245;es de tratamento para a dor?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">P10. Voc&#234; foi autorizado a participar das decis&#245;es sobre seu tratamento para a dor tanto quanto gostaria?</td><td align="left" colspan="2" rowspan="1">P10. Voc&#234; participou das decis&#245;es sobre seu tratamento para a dor tanto quanto gostaria?</td></tr><tr><td align="left" rowspan="1" colspan="1">De forma alguma</td><td align="left" rowspan="1" colspan="1">Bastante</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Bastante</td></tr><tr><td align="left" colspan="2" rowspan="1">P11. Circule o n&#250;mero que melhor representa o qu&#227;o satisfeito(a) voc&#234; est&#225; com os resultados do seu tratamento para dor desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P11. Assinale o n&#250;mero que melhor representa o qu&#227;o satisfeito(a) voc&#234; est&#225; com os resultados do seu tratamento para dor desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Extremamente insatisfeito</td><td align="left" rowspan="1" colspan="1">Extremamente satisfeito</td><td align="left" rowspan="1" colspan="1">Extremamente insatisfeito</td><td align="left" rowspan="1" colspan="1"> Extremamente satisfeito</td></tr><tr><td align="left" colspan="2" rowspan="1">P12. Voc&#234; usou ou recebeu algum m&#233;todo n&#227;o medicamentoso para al&#237;vio da dor?</td><td align="left" colspan="2" rowspan="1">P12. Voc&#234; solicitou ou recebeu algum tratamento n&#227;o medicamentoso para al&#237;vio da dor?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Se sim, marque todos que se aplicam:</td><td align="left" colspan="2" rowspan="1">Se sim, marque todos que se aplicam:</td></tr><tr><td align="left" colspan="2" rowspan="1">Bolsa de gelo Medita&#231;&#227;o<break/>Respirar profundamente Calor<break/>Acupuntura Prece Conversas com a equipe m&#233;dica<break/>Caminhada Massagem Conversas com amigos ou familiares<break/>Relaxamento Imagens ou visualiza&#231;&#227;o</td><td align="left" colspan="2" rowspan="1">Bolsa de gelo Medita&#231;&#227;o Respira&#231;&#227;o profunda Calor<break/>Acupuntura Ora&#231;&#245;es Conversas com a equipe m&#233;dica<break/>Caminhada Massagem Conversas com amigos ou familiares<break/>Relaxamento Imagens ou visualiza&#231;&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">TENS (Neuroestimula&#231;&#227;o El&#233;trica Transcut&#226;nea)</td><td align="left" colspan="2" rowspan="1">TENS (Neuroestimula&#231;&#227;o El&#233;trica Transcut&#226;nea)</td></tr><tr><td align="left" colspan="2" rowspan="1">Distra&#231;&#245;es (como ver TV, ouvir m&#250;sica, ler etc.)</td><td align="left" colspan="2" rowspan="1">Distra&#231;&#245;es (como ver TV, ouvir m&#250;sica, ler etc.)</td></tr><tr><td align="left" colspan="2" rowspan="1">Outras (por favor, descreva):</td><td align="left" colspan="2" rowspan="1">Outras (por favor, descreva):</td></tr><tr><td align="left" colspan="2" rowspan="1">P13. Voc&#234; teve alguma condi&#231;&#227;o de dor persistente por tr&#234;s meses ou mais antes de vir ao hospital para a cirurgia?</td><td align="left" colspan="2" rowspan="1">P13. Antes de vir ao hospital para esta cirurgia voc&#234; sentiu alguma condi&#231;&#227;o de dor persistente por tr&#234;s meses ou mais?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">a. Se sim, qu&#227;o intensa foi a dor na maior parte do tempo?<break/>Por favor, circule o n&#250;mero que indica isso.</td><td align="left" colspan="2" rowspan="1">a. Se sim, qual a intensidade da dor na maior parte do tempo? Por favor, assinale o n&#250;mero que indica esta intensidade.</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">b. Se teve dor, onde esta dor persistente estava localizada?</td><td align="left" colspan="2" rowspan="1">b. Se sentiu dor, onde esta dor persistente estava localizada?</td></tr><tr><td align="left" colspan="2" rowspan="1">Local da cirurgia Outro local Ambos (local da cirurgia e outro local)</td><td align="left" colspan="2" rowspan="1">Local da cirurgia Outro local Ambos (local da cirurgia e outro local)</td></tr><tr><td align="left" colspan="2" rowspan="1">Obrigado por seu tempo e contribui&#231;&#227;o</td><td align="left" colspan="2" rowspan="1">Obrigado por seu tempo e sua participa&#231;&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Para ser preenchido pelo assistente de pesquisa<break/>C&#243;digo do assistente de pesquisa:<break/>Paciente foi entrevistado: Sim N&#227;o<break/>Se sim, por favor assinale o(s) motivo(s):<break/>Doente/fraco demais<break/>Sentia muita dor<break/>Necessitava de ajuda<break/>N&#227;o entendia as escalas<break/>Motivos t&#233;cnicos (paciente estava sem &#243;culos/&#233; cego; n&#227;o consegue sentar-se; &#233; analfabeto; bra&#231;o estava engessado etc.)</td><td align="left" colspan="2" rowspan="1">Para ser preenchido pelo assistente de pesquisa<break/>C&#243;digo do assistente de pesquisa:<break/>Paciente foi entrevistado? Sim N&#227;o<break/>Se sim, por favor assinale o(s) motivo(s):<break/>Doente/fraco demais <break/>Sentia muita dor<break/>Necessitava de ajuda<break/>N&#227;o entendia as escalas<break/>Motivos t&#233;cnicos (paciente estava sem &#243;culos/&#233; cego; n&#227;o consegue sentar-se; &#233; analfabeto; bra&#231;o estava engessado etc.)</td></tr></tbody></table></table-wrap><p>In the back-translation phase, all identified discrepancies were considered synonymous words, and we selected the terms deemed more commonly used in Brazilian Portuguese.</p></sec><sec><title>Pretest</title><p>A total of 30 patients participated in the pretest phase. The majority of participants (23; 76.6%) were female, 22 (70.2%) were between 18 and 39 years old, and 8 (29.8%) were between 40 and 60 years old. Additionally, 26 (86%) were married, and 19 (63.2%) had completed high school, while 11 (36.8%) had a higher education degree. Regarding employment status, 21 participants (70%) were employed.</p><p>In terms of clinical data, the majority (19; 63.2%) underwent medium- to large-scale surgeries, while 11 (36.3%) had hypertension as a comorbidity. Nineteen (63.2%) received general anesthesia, and no participants experienced operating room complications. All participants received analgesic medication in the operating room and continued with scheduled analgesia for the first 24 hours postoperatively.</p><p>All pretesting participants reported clearly understanding the instrument&#8217;s questions. Based on this result, the instrument was considered validated in terms of adequacy and applicability, leading to the final version of the questionnaire after the pretest, named International Pain Outcomes (IPO) &#8211; Brazilian Portuguese version (<xref rid="f1" ref-type="fig">Figure 1</xref>).</p><p>
<fig position="float" id="f1" orientation="portrait"><label>Figure 1</label><caption><title>International Pain Outcomes &#8211; Brazilian Portuguese version</title></caption><graphic position="float" orientation="portrait" xlink:href="0034-7167-reben-78-03-e20240346-gf01.jpg"/></fig>
</p></sec><sec><title>Psychometric validation</title><p>Among the 360 participants, 208 (57.8%) were male. The mean age was 55.88 years (&#177;16.37), and the mean surgery duration was 123.44 minutes (&#177;84.39). The results showed that strong and very strong correlations were indicators of convergent validity for conceptually similar items between the instruments analyzed. All correlations between corresponding items in both scales were statistically significant (p &#8804; 0.001), demonstrating that the IPO is capable of assessing pain in patients to the same extent as the BPI, an instrument that has already been validated and widely used in clinical practice (<xref rid="t2" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="t2" orientation="portrait"><label>Table 1</label><caption><title>Convergent validity (N = 360) considering the Brief Pain Inventory, Uberaba, Minas Gerais, Brazil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="2" colspan="1">IPO</th><th align="center" colspan="2" rowspan="1">BPI</th></tr><tr><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Number representing the worst pain since surgery</td><td align="center" colspan="2" rowspan="1">Number best describing the worst pain in the last 24 h</td></tr><tr><td align="center" rowspan="1" colspan="1">0.933</td><td align="center" rowspan="1" colspan="1">&#8804; 0.001</td></tr><tr><td align="left" rowspan="2" colspan="1">Number representing the least intense pain since surgery</td><td align="center" colspan="2" rowspan="1">Number best describing the least intense pain in the last 24 h</td></tr><tr><td align="center" rowspan="1" colspan="1">0.867</td><td align="center" rowspan="1" colspan="1">&#8804; 0.001</td></tr><tr><td align="left" rowspan="2" colspan="1">Number representing how much pain interfered with activities out of bed</td><td align="center" colspan="2" rowspan="1">Number best describing how much pain interfered with walking ability</td></tr><tr><td align="center" rowspan="1" colspan="1">0.806</td><td align="center" rowspan="1" colspan="1">&#8804; 0.001</td></tr><tr><td align="left" rowspan="2" colspan="1">Number representing how much pain interfered with sleep</td><td align="center" colspan="2" rowspan="1">Number best describing how much pain interfered with sleep</td></tr><tr><td align="center" rowspan="1" colspan="1">0.786</td><td align="center" rowspan="1" colspan="1">&#8804; 0.001</td></tr><tr><td align="left" rowspan="2" colspan="1">Pain relief level after treatments used</td><td align="center" colspan="2" rowspan="1">Improvement provided by treatments or medications</td></tr><tr><td align="center" rowspan="1" colspan="1">0.809</td><td align="center" rowspan="1" colspan="1">&#8804; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>
<italic toggle="yes">IPO &#8211; International Pain Outcomes; BPI &#8211; Brief Pain Inventory.</italic>
</p></fn></table-wrap-foot></table-wrap><p>The internal consistency analysis was assessed using the Kuder-Richardson coefficient (KR-20) for dichotomous items and Cronbach&#8217;s alpha for quantitative items. For the 0-to-10 scales, Cronbach&#8217;s alpha was 0.796, which falls within the acceptable range for instrument reliability.</p><p>We also assessed interobserver reliability using Kappa statistics and the ICC between observers for each instrument item. All Kappa results (<xref rid="t3" ref-type="table">Table 2</xref>) were equal to 1, and the ICC exceeded 0.999, both indicating high interobserver reliability (<xref rid="t4" ref-type="table">Table 3</xref>).</p><table-wrap position="float" id="t3" orientation="portrait"><label>Table 2</label><caption><title>Interobserver reliability results (n = 54) using the Kappa coefficient, Uberaba, Minas Gerais, Brazil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Items</th><th align="center" colspan="4" rowspan="1">Observer 1</th><th align="center" colspan="4" rowspan="1">Observer 2</th><th align="center" rowspan="3" colspan="1">Proportion of agreement (%)</th><th align="center" rowspan="3" colspan="1">Kappa</th><th align="center" rowspan="3" colspan="1">
<italic toggle="yes">p</italic> value</th></tr><tr><th align="center" colspan="2" rowspan="1">Yes</th><th align="center" colspan="2" rowspan="1">No</th><th align="center" colspan="2" rowspan="1">Yes</th><th align="center" colspan="2" rowspan="1">No</th></tr><tr><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Did you manage to get out of bed?</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">88.9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">11.11</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">88.9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">11.11</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Would you have liked to receive more treatment than you did?</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18.5</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">81.5</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18.6</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">81.4</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Did you receive information about your pain treatment options?</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">38.9</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">61.1</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">38.9</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">61.1</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-pharmacological treatment</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">9.3</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">90.7</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">9.3</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">90.7</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Before this surgery, did you have persistent pain for three months or more?</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">42.6</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">57.4</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">42.6</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">57.4</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t4" orientation="portrait"><label>Table 3</label><caption><title>Interobserver reliability results (n = 54) using the Intraclass Correlation Coefficient, Uberaba, Minas Gerais, Brazil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Itens</th><th align="center" colspan="5" rowspan="1">Observer 1</th><th align="center" colspan="6" rowspan="1">Observer 2</th><th align="center" rowspan="2" colspan="1">
<italic toggle="yes">p</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">Min.</th><th align="center" rowspan="1" colspan="1">Max.</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">SD</th><th align="center" rowspan="1" colspan="1">Min.</th><th align="center" rowspan="1" colspan="1">Max.</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">SD</th><th align="center" rowspan="1" colspan="1">ICC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Worst pain</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5.65</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">3.43</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5.65</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">3.43</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Least pain</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.41</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.51</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.41</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2.51</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Frequency of severe pain</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">36.85</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">35.97</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">36.85</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">35.97</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interfered with performing activities in bed</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.89</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4.17</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.89</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4.17</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interfered with breathing or coughing</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3.96</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.34</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3.96</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4.34</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interfered with sleeping</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.13</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">4.15</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.2</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">4.20</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Made you feel anxious</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.33</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4.05</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.33</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4.05</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Made you feel helpless</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.28</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.61</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.28</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.61</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Experienced nausea as a side effect</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.47</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.47</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Experienced drowsiness</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.06</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.06</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4.11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Experienced itching as a side effect</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.02</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.29</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.02</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.29</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Experienced dizziness as a side effect</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.57</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.44</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.57</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.44</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Pain relief from treatments used</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">36.70</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">36.70</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Participation in pain treatment decisions</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5.85</td><td align="center" rowspan="1" colspan="1">9.5</td><td align="center" rowspan="1" colspan="1">4.64</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5.85</td><td align="center" rowspan="1" colspan="1">9.5</td><td align="center" rowspan="1" colspan="1">4.64</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Satisfaction with pain treatment outcomes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9.33</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1.64</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9.33</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1.64</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Adapting and validating outcome assessment instruments available in the international literature is a viable option as it saves time and resources while enabling comparisons between studies conducted in different countries or among individuals from diverse backgrounds<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>The cross-cultural adaptation of the IPO for use in Brazil followed a systematic approach, adhering to internationally recommended guidelines for the cultural adaptation of measurement instruments, as described by Ferrer et al.<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup> and Beaton et al. (2007)<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>. Modifications were made to account for the specific characteristics of the target population during the adaptation process, ensuring that the instrument would be well understood and effectively applied. According to the literature, culturally equivalent translation is essential to ensure that the terms used in the instrument align with the experiences and context of the target population. If these terms are irrelevant to the population&#8217;s reality, they should be modified accordingly<sup>(<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>)</sup>.</p><p>In this study, modifications to the translated version&#8217;s items were guided by expert recommendations and based on principles that reinforce the importance of respecting the autonomy of individuals who have undergone surgical procedures and experienced postoperative pain. The pretest phase reinforced the objective of ensuring clarity and precision in word choice, allowing the translated version to be easily understood by the target population while maintaining the originality of the source instrument<sup>(<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>)</sup>.</p><p>Regarding convergent validity, the results indicated a strong to very strong correlation between specific items that shared conceptual similarities across both instruments, demonstrating that the IPO can assess pain in patients to the same extent as the IBD, a validated instrument widely used in clinical practice. In contrast, Erden et al.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>, when combining the IPO questionnaire with the IBD to validate the Turkish version of the IPO, found a moderate positive correlation between similar items in both scales.</p><p>In the internal consistency analysis, Cronbach&#8217;s alpha was 0.796. This value is similar to that reported in the validation study of the original instrument<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>, in which the IPO was applied to 9,727 patients in ten languages across eight European countries and Israel. In that study, the overall alpha was high (0.86), and the psychometric quality of the instrument was deemed satisfactory.</p><p>In the validation study of the Turkish version of the IPO, the questionnaire was administered to 250 surgical patients (98 men and 152 women) between January 2015 and January 2016. Consistent with our findings, internal consistency showed a Cronbach&#8217;s alpha of 0.88. The authors concluded that the Turkish version of the IPO is a reliable and valid tool for assessing and evaluating the quality of postoperative pain management in the Turkish population<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>In contrast, the validation study of the Danish version of the IPO evaluated 56 patients with acute abdominal pain, assessing internal consistency through an item-level analysis of the instrument. The results showed a Cronbach&#8217;s alpha &#8805; 0.7 for the pain, satisfaction, activity, and emotion subscales; 0.69 for the satisfaction subscale in the &#8220;hospitalization&#8221; domain; &#8804; 0.7 for the safety subscale; and &#8804; 0.62 for the patient barrier subscale. The study did not report a Cronbach&#8217;s alpha for the overall scale<sup>(<xref rid="B26" ref-type="bibr">26</xref>)</sup>.</p><p>Moreover, in the validation study of the IPO involving 268 Danish and 311 Australian patients, the results demonstrated unsatisfactory internal consistency, with a Cronbach&#8217;s alpha of 0.54 for the Danish sample and 0.63 for the Australian sample<sup>(<xref rid="B27" ref-type="bibr">27</xref>)</sup>. Supporting these findings, the questionnaire used to validate the Icelandic version was applied to 143 inpatients in a university hospital, yielding a Cronbach&#8217;s alpha of 0.42 for the total scale<sup>(<xref rid="B28" ref-type="bibr">28</xref>)</sup>.</p><p>The level of agreement between observers regarding the instrument&#8217;s scores was verified in this study through interobserver analysis, assessed using the Kappa coefficient and the ICC. All Kappa values were equal to 1, and the ICC results exceeded 0.999, indicating high reliability. The approach adopted in this study to evaluate the reliability of the questionnaire following cross cultural adaptation was not used to validate the original instrument. However, it achieved statistically satisfactory results.</p><p>Measurements obtained with valid and reliable instruments are essential for identifying effective pain treatment strategies and assessing improvements in pain management quality in clinical practice. The following international studies have reported using the IPO for postoperative pain assessment and management optimization.</p><p>To implement quality improvement projects for pain management in different countries, the PAIN OUT group used the IPO to evaluate postoperative pain management in 10,415 patients from 105 surgical wards across 64 hospitals in Mexico, China, and eight European countries. Among these patients, 48.7% reported worst pain scores between 7 and 10, while 24.3% experienced severe pain for more than 50% of the time since surgery, and 34% reported severe functional and emotional interference due to pain. The results indicated that postoperative pain management quality in the assessed countries requires improvement<sup>(<xref rid="B29" ref-type="bibr">29</xref>)</sup>.</p><p>To report on the development and feasibility of the PAIN OUT project, Zaslansky et al. (2015)<sup>(<xref rid="B30" ref-type="bibr">30</xref>)</sup> employed the IPO questionnaire to evaluate, on the first postoperative day, 6,347 adult patients who had undergone orthopedic or general surgery in eleven medical centers across Europe and Israel. Their findings demonstrated that the PAIN OUT project provides healthcare professionals with standardized and validated instruments for outcome measurement and feedback, supporting their decision-making process to optimize pain management for their patients.</p><p>From this perspective, regular pain assessments are recommended after surgery to increase healthcare professionals&#8217; awareness, enabling them to provide patients with specific and effective analgesic approaches<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>Considering the objectives of the present study, the cross-cultural adaptation process and psychometric validation of the International Pain Outcomes (IPO) questionnaire &#8211; Brazilian Portuguese version were conducted appropriately, ensuring its validity.</p><sec><title>Study limitations</title><p>One limitation of this study lies in the use of different validation methodologies across distinct cultural contexts. Nevertheless, this study adhered to the validation process established in the original instrument&#8217;s development.</p></sec><sec><title>Contributions to the field</title><p>This pain assessment instrument can be applied in the Brazilian context, assisting healthcare professionals in evaluating the intensity and severity of postoperative pain, side effects, physical and emotional aspects, functional ability, and self-care of patients after surgery. Its application will support effective postoperative pain management, quality care, and patient safety.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>The International Pain Outcomes (IPO) questionnaire &#8211; Brazilian Portuguese version was considered adequate, culturally equivalent to the original, validated for Brazilian Portuguese, and reliable for application in postoperative patient care. This instrument enables proper and safe pain management, contributing to the prevention of complications during this period.</p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>The authors thank the National Council for Scientific and Technological Development (CNPq) for awarding the Research Productivity Grant (PQ-307468/2021-6) to Barbosa MH.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>FUNDING:</bold> This study was supported by the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) and the Minas Gerais Research Support Foundation (FAPEMIG/PPM-APQ-00121-17).</p></fn></fn-group><sec sec-type="data-availability" specific-use="data-in-article"><label>AVAILABILITY OF DATA AND MATERIAL</label><p>The research data are available within the article.</p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>PHOLR</given-names></name><name name-style="western"><surname>Sales</surname><given-names>LF</given-names></name><name name-style="western"><surname>Medeiros</surname><given-names>AM</given-names></name><name name-style="western"><surname>Santos</surname><given-names>MY</given-names></name><name name-style="western"><surname>Presotto</surname><given-names>L</given-names></name></person-group><article-title>Advances and current strategies in postoperative pain management: from pharmacotherapy to multidisciplinary approach</article-title><source>Braz J Implantol Health Sci.</source><year>2024</year><volume>6</volume><issue>5</issue><fpage>824</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.36557/2674-8169.2024v6n5p824-837</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>Hua</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><etal/></person-group><article-title>Effects of virtual reality on relieving postoperative pain in surgical patients: a systematic review and meta-analysis</article-title><source>Int J Surg.</source><year>2020</year><volume>82</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2020.08.033</pub-id><pub-id pub-id-type="pmid">32882400</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraimer</surname><given-names>K</given-names></name><name name-style="western"><surname>Scott</surname><given-names>B</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>N</given-names></name><name name-style="western"><surname>Geltzeiler</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>T</given-names></name><name name-style="western"><surname>Detwiller</surname><given-names>K</given-names></name></person-group><article-title>Postoperative pain following coblation of sinonasal hereditary hemorrhagic telangiectasias</article-title><source>Ann Otol Rhinol Laryngol.</source><year>2024</year><volume>133</volume><issue>1</issue><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1177/00034894231182212</pub-id><pub-id pub-id-type="pmid">37377016</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lappalainen</surname><given-names>E</given-names></name><name name-style="western"><surname>Ruohoaho</surname><given-names>UM</given-names></name><name name-style="western"><surname>Kokki</surname><given-names>H</given-names></name><name name-style="western"><surname>Aaltomaa</surname><given-names>S</given-names></name><name name-style="western"><surname>Anttila</surname><given-names>M</given-names></name><name name-style="western"><surname>Gissler</surname><given-names>M</given-names></name><etal/></person-group><article-title>Postoperative pain in a prospectively assessed surgical short-stay cohort: a subgroup analysis</article-title><source>Acta Anaesthesiol Scand.</source><year>2022</year><volume>66</volume><issue>10</issue><fpage>1193</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1111/aas.14139</pub-id><pub-id pub-id-type="pmid">36054341</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>NI</given-names></name><name name-style="western"><surname>Kehlet</surname><given-names>H</given-names></name><name name-style="western"><surname>Gromov</surname><given-names>K</given-names></name><name name-style="western"><surname>Troelsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Husted</surname><given-names>H</given-names></name><name name-style="western"><surname>Varnum</surname><given-names>C</given-names></name><etal/></person-group><article-title>High-dose dexamethasone in low pain responders undergoing total knee arthroplasty: a randomised double-blind trial</article-title><source>Br J Anaesth</source><year>2023</year><volume>130</volume><issue>3</issue><fpage>322</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2022.10.038</pub-id><pub-id pub-id-type="pmid">36526481</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marjanovi&#263; Kavangh</surname><given-names>M</given-names></name><name name-style="western"><surname>Kru&#382;i&#263;</surname><given-names>S</given-names></name><name name-style="western"><surname>&#272;uri&#263; Vukovi&#263;</surname><given-names>K</given-names></name><name name-style="western"><surname>Bumber</surname><given-names>B</given-names></name></person-group><article-title>Postoperative pain following functional endoscopic sinus surgery</article-title><source>Acta Clin Croat</source><year>2022</year><volume>61</volume><issue>Suppl 4</issue><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.20471/acc.2022.61.s4.7</pub-id><pub-id pub-id-type="pmid">37250667</pub-id><pub-id pub-id-type="pmcid">PMC10218080</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schultz</surname><given-names>H</given-names></name><name name-style="western"><surname>Abrahamsen</surname><given-names>L</given-names></name><name name-style="western"><surname>Rekvad</surname><given-names>LE</given-names></name><name name-style="western"><surname>Skr&#230;p</surname><given-names>U</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>TS</given-names></name><name name-style="western"><surname>M&#246;ller</surname><given-names>S</given-names></name><etal/></person-group><article-title>Patient-controlled oral analgesia at acute abdominal pain: A before-and-after intervention study of pain management during hospital stay</article-title><source>Appl. Nurs. Res.</source><year>2019</year><issue>46</issue><fpage>43</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.apnr.2019.02.006</pub-id><pub-id pub-id-type="pmid">30853075</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherwood</surname><given-names>G</given-names></name><name name-style="western"><surname>Mcneill</surname><given-names>J</given-names></name></person-group><article-title>Reflective practice: providing safe quality patient-centered pain management</article-title><source>Pain Manag.</source><year>2017</year><volume>7</volume><issue>3</issue><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.2217/pmt-2016-0053</pub-id><pub-id pub-id-type="pmid">28147900</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnabel</surname><given-names>A</given-names></name><name name-style="western"><surname>Yahiaoui-Doktor</surname><given-names>M</given-names></name><name name-style="western"><surname>Meissner</surname><given-names>W</given-names></name><name name-style="western"><surname>Zahn</surname><given-names>PK</given-names></name><name name-style="western"><surname>Pogatzki-Zahn</surname><given-names>EM</given-names></name></person-group><article-title>Predicting poor postoperative acute pain outcome in adults: an international, multicentre database analysis of risk factors in 50,005 patients</article-title><source>Pain Rep.</source><year>2020</year><volume>5</volume><issue>4</issue><fpage>e831</fpage><pub-id pub-id-type="doi">10.1097/PR9.0000000000000831</pub-id><pub-id pub-id-type="pmid">32766467</pub-id><pub-id pub-id-type="pmcid">PMC7390596</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>H</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>K</given-names></name><name name-style="western"><surname>Nozaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Psychometric evaluation of the Chinese version of the revised American Pain Society Patient Outcome Questionnaire concerning pain management in Chinese orthopedic patients</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><issue>5</issue><fpage>e0178268</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0178268</pub-id><pub-id pub-id-type="pmid">28542551</pub-id><pub-id pub-id-type="pmcid">PMC5444797</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubljanin Raspopovi&#263;</surname><given-names>E</given-names></name><name name-style="western"><surname>Meissner</surname><given-names>W</given-names></name><name name-style="western"><surname>Zaslansky</surname><given-names>R</given-names></name><name name-style="western"><surname>Kadija</surname><given-names>M</given-names></name><name name-style="western"><surname>Tomanovi&#263; Vujadinovi&#263;</surname><given-names>S</given-names></name><name name-style="western"><surname>Tuli&#263;</surname><given-names>G</given-names></name></person-group><article-title>Associations between early postoperative pain outcome measures and late functional outcomes in patients after knee arthroplasty</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><issue>7</issue><fpage>e0253147</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0253147</pub-id><pub-id pub-id-type="pmid">34320012</pub-id><pub-id pub-id-type="pmcid">PMC8318305</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalala</surname><given-names>B</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>D</given-names></name><name name-style="western"><surname>Nizeyimana</surname><given-names>F</given-names></name><name name-style="western"><surname>Thakore</surname><given-names>S</given-names></name><name name-style="western"><surname>Myukiyehe</surname><given-names>JP</given-names></name><name name-style="western"><surname>Twagirumugabi</surname><given-names>T</given-names></name><etal/></person-group><article-title>A survey of pediatric postoperative pain management in Rwanda</article-title><source>Can J Anesth</source><year>2021</year><volume>68</volume><fpage>1718</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s12630-021-02082-3</pub-id><pub-id pub-id-type="pmid">34350558</pub-id><pub-id pub-id-type="pmcid">PMC8336667</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nie</surname><given-names>ZB</given-names></name><name name-style="western"><surname>Li</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Lu</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>YY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name></person-group><article-title>Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: a meta-analysis</article-title><source>Medicine (Baltimore)</source><year>2022</year><volume>101</volume><issue>3</issue><fpage>e28615</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000028615</pub-id><pub-id pub-id-type="pmid">35060534</pub-id><pub-id pub-id-type="pmcid">PMC8772727</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>H</given-names></name><name name-style="western"><surname>Stafseth</surname><given-names>SK</given-names></name></person-group><article-title>Documentation for Assessing Pain in Postoperative Pain Management Pre- and Post-intervention</article-title><source>J Perianesth Nurs.</source><year>2023</year><volume>38</volume><issue>1</issue><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jopan.2022.05.079</pub-id><pub-id pub-id-type="pmid">35970659</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erden</surname><given-names>S</given-names></name><name name-style="western"><surname>Karada&#287;</surname><given-names>M</given-names></name><name name-style="western"><surname>Demir</surname><given-names>SG</given-names></name><name name-style="western"><surname>Atasayar</surname><given-names>S</given-names></name><name name-style="western"><surname>Y&#252;cel</surname><given-names>BO</given-names></name><name name-style="western"><surname>Kalkan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cross-cultural adaptation, validity, and reliability of the Turkish version of revised American Pain Society patient outcome questionnaire for surgical patients</article-title><source>Agri.</source><year>2018</year><volume>30</volume><issue>2</issue><fpage>39</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.5505/agri.2018.21548</pub-id><pub-id pub-id-type="pmid">29738065</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Pain Out Improvement in Postoperative Pain Outcome</collab></person-group><source>Question&#225;rio International Pain Outcomes (IPO) [Internet]</source><year>2019</year><date-in-citation>cited 2019 Apr 28</date-in-citation><comment>Available from: <ext-link xlink:href="https://www.pain-out.eu/painout/services/downloads" ext-link-type="uri">https://www.pain-out.eu/painout/services/downloads</ext-link></comment></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>DB</given-names></name><name name-style="western"><surname>Polomano</surname><given-names>RC</given-names></name><name name-style="western"><surname>Pellino</surname><given-names>TA</given-names></name><name name-style="western"><surname>Turk</surname><given-names>DC</given-names></name><name name-style="western"><surname>McCracken</surname><given-names>LM</given-names></name><name name-style="western"><surname>Sherwood</surname><given-names>G</given-names></name><etal/></person-group><article-title>Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) for quality improvement of pain management in hospitalized adults: preliminary psychometric evaluation</article-title><source>J Pain</source><year>2010</year><volume>11</volume><issue>11</issue><fpage>1172</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2010.02.012</pub-id><pub-id pub-id-type="pmid">20400379</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothaug</surname><given-names>J</given-names></name><name name-style="western"><surname>Zaslansky</surname><given-names>R</given-names></name><name name-style="western"><surname>Schwenkglenks</surname><given-names>M</given-names></name><name name-style="western"><surname>Komann</surname><given-names>M</given-names></name><name name-style="western"><surname>Allvin</surname><given-names>R</given-names></name><name name-style="western"><surname>Backstr&#246;m</surname><given-names>R</given-names></name><etal/></person-group><article-title>Patients&#8217; perception of postoperative pain management: validation of the International Pain Outcomes (IPO) questionnaire</article-title><source>J Pain</source><year>2013</year><volume>14</volume><issue>11</issue><fpage>1361</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2013.05.016</pub-id><pub-id pub-id-type="pmid">24021577</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>KA</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mendonza</surname><given-names>TR</given-names></name><name name-style="western"><surname>Cleeland</surname><given-names>CS</given-names></name></person-group><article-title>Validation of brief pain inventory to Brazilian patients with pain</article-title><source>Support Care Cancer</source><year>2011</year><volume>19</volume><issue>4</issue><fpage>505</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s00520-010-0844-7</pub-id><pub-id pub-id-type="pmid">20221641</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrer</surname><given-names>M</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>J</given-names></name><name name-style="western"><surname>Prieto</surname><given-names>L</given-names></name><name name-style="western"><surname>Plaza</surname><given-names>V</given-names></name><name name-style="western"><surname>Mons&#243;</surname><given-names>E</given-names></name><name name-style="western"><surname>Marrades</surname><given-names>R</given-names></name><etal/></person-group><article-title>Validity and reliability of the St George&#8217;s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example</article-title><source>Eur Respir J.</source><year>1996</year><volume>9</volume><issue>6</issue><fpage>1160</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1183/09031936.96.09061160</pub-id><pub-id pub-id-type="pmid">8804932</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Beaton</surname><given-names>D</given-names></name><name name-style="western"><surname>Bombardier</surname><given-names>C</given-names></name><name name-style="western"><surname>Guillemin</surname><given-names>F</given-names></name><name name-style="western"><surname>Ferraz</surname><given-names>MB</given-names></name></person-group><source>Recommendations for the cross-cultural adaptation of the DASH &amp; QuickDASH outcome measures[Internet]</source><publisher-name>Institute for Work &amp; Health</publisher-name><year>2007</year><date-in-citation>cited 2019 Apr 28</date-in-citation><comment>Available from: <ext-link xlink:href="http://www.dash.iwh.on.ca/sites/dash/files/downloads/cross_cultural_adaptation_2007.pdf" ext-link-type="uri">www.dash.iwh.on.ca/sites/dash/files/downloads/cross_cultural_adaptation_2007.pdf</ext-link></comment></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cummings</surname><given-names>SR</given-names></name><name name-style="western"><surname>Steawart</surname><given-names>A</given-names></name><name name-style="western"><surname>Hulley</surname><given-names>SB</given-names></name></person-group><part-title>Elabora&#231;&#227;o de question&#225;rios e instrumentos de coleta de dados</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Hulley</surname><given-names>SB</given-names></name></person-group><source>Delineando a pesquisa cl&#237;nica: uma abordagem epidemiol&#243;gica</source><publisher-loc>Porto Alegre</publisher-loc><publisher-name>Artmed</publisher-name><year>2003</year><fpage>265</fpage><lpage>281</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalla Nora</surname><given-names>CR</given-names></name><name name-style="western"><surname>Zoboli</surname><given-names>E</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>MM</given-names></name></person-group><article-title>Validation by experts: importance in translation and adaptation of instruments</article-title><source>Rev Ga&#250;cha Enferm.</source><year>2017</year><volume>38</volume><issue>3</issue><fpage>e64851</fpage><pub-id pub-id-type="doi">10.1590/1983-1447.2017.03.64851</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simch</surname><given-names>FBL</given-names></name><name name-style="western"><surname>Viera</surname><given-names>CS</given-names></name><name name-style="western"><surname>Santos</surname><given-names>MB</given-names></name><name name-style="western"><surname>Toso</surname><given-names>BRGO</given-names></name></person-group><article-title>Transcultural adaptation and validation of the instrument Parental Health Literacy Activities Test (PHLAT)</article-title><source>Sa&#250;de Debate</source><year>2020</year><volume>44</volume><issue>127</issue><pub-id pub-id-type="doi">10.1590/0103-1104202012704</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pernambuco</surname><given-names>L</given-names></name><name name-style="western"><surname>Espelt</surname><given-names>A</given-names></name><name name-style="western"><surname>Magalhaes-Junior</surname><given-names>HV</given-names></name><etal/></person-group><article-title>Recommendations for elaboration, transcultural adaptation and validation process of tests in Speech, Hearing and Language Pathology</article-title><source>CoDAS</source><year>2017</year><volume>29</volume><issue>3</issue><fpage>e2016021729</fpage><pub-id pub-id-type="doi">10.1590/2317-1782/20172016217</pub-id><pub-id pub-id-type="pmid">28614460</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schultz</surname><given-names>H</given-names></name><name name-style="western"><surname>Skr&#230;p</surname><given-names>U</given-names></name><name name-style="western"><surname>Schultz Larsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Rekvad</surname><given-names>LE</given-names></name><name name-style="western"><surname>Littau-Larsen</surname><given-names>J</given-names></name></person-group><article-title>Psychometric evaluation of the Danish version of a modified Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R-D) for patients hospitalized with acute abdominal pain</article-title><source>Scand J Pain</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>117</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1515/sjpain-2018-0106</pub-id><pub-id pub-id-type="pmid">30352045</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botti</surname><given-names>M</given-names></name><name name-style="western"><surname>Khaw</surname><given-names>D</given-names></name><name name-style="western"><surname>J&#248;rgensen</surname><given-names>EB</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>B</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>S</given-names></name><name name-style="western"><surname>Redley</surname><given-names>B</given-names></name></person-group><article-title>Cross-cultural examination of the structure of the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R)</article-title><source>J Pain</source><year>2015</year><volume>16</volume><issue>8</issue><fpage>727</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2015.03.016</pub-id><pub-id pub-id-type="pmid">25998207</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zo&#235;ga</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>S</given-names></name><name name-style="western"><surname>Gunnarsdottir</surname><given-names>S</given-names></name></person-group><article-title>Evaluating the quality of pain management in a hospital setting: testing the psychometric properties of the Icelandic version of the revised American Pain Society patient outcome questionnaire</article-title><source>Pain Manag Nurs.</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>143</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.pmn.2012.08.001</pub-id><pub-id pub-id-type="pmid">23318415</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Pain Out Research Group Jena, Chinese Pain Out Network, Dutch Pain Out Network, M&#233;xican Pain Out Network, Serbian Pain Out Network, Spanish Pain Out Network</collab><etal/></person-group><article-title>Status quo of pain-related patient-reported outcomes and perioperative pain management in 10,415 patients from 10 countries: analysis of registry data</article-title><source>Eur J Pain</source><year>2022</year><volume>00</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/ejp.2024</pub-id><pub-id pub-id-type="pmid">35996995</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaslansky</surname><given-names>R</given-names></name><name name-style="western"><surname>Rothaug</surname><given-names>J</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>CR</given-names></name><name name-style="western"><surname>B&#228;ckstr&#246;m</surname><given-names>R</given-names></name><name name-style="western"><surname>Brill</surname><given-names>S</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Pain Out: the making of an international acute pain registry</article-title><source>Eur J Pain</source><year>2015</year><volume>19</volume><issue>4</issue><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1002/ejp.571</pub-id><pub-id pub-id-type="pmid">25132607</pub-id></element-citation></ref></ref-list></back><sub-article article-type="translation" id="s1" xml:lang="pt"><front-stub><article-id pub-id-type="doi">10.1590/0034-7167-2024-0346pt</article-id><article-categories><subj-group subj-group-type="heading"><subject>Artigo Original</subject></subj-group></article-categories><title-group><article-title>
<italic toggle="yes">International Pain Outcomes</italic> (IPO) &#8211; vers&#227;o portugu&#234;s do Brasil: adapta&#231;&#227;o transcultural e valida&#231;&#227;o psicom&#233;trica</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8431-6712</contrib-id><name name-style="western"><surname>Felix</surname><given-names initials="MMDS">Marcia Marques dos Santos</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff4" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1591-2542</contrib-id><name name-style="western"><surname>Tibola</surname><given-names initials="TSA">Talita Silva Alves</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff4" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4487-9232</contrib-id><name name-style="western"><surname>Raponi</surname><given-names initials="MBG">Maria Beatriz Guimar&#227;es</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff5" ref-type="aff">II</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1984-0486</contrib-id><name name-style="western"><surname>Silva</surname><given-names initials="ACRD">Ana C&#237;ntia Ribeiro da</given-names></name><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff4" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0724-8124</contrib-id><name name-style="western"><surname>Calegari</surname><given-names initials="IB">Isadora Braga</given-names></name><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff4" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7923-8497</contrib-id><name name-style="western"><surname>Faria</surname><given-names initials="MFD">Ma&#237;la Fidalgo de</given-names></name><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><xref rid="aff4" ref-type="aff">I</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2537-3909</contrib-id><name name-style="western"><surname>Pires</surname><given-names initials="PDS">Patr&#237;cia da Silva</given-names></name><role>revis&#227;o final com participa&#231;&#227;o cr&#237;tica e intelectual no manuscrito</role><xref rid="aff6" ref-type="aff">III</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2749-2802</contrib-id><name name-style="western"><surname>Barbosa</surname><given-names initials="MH">Maria Helena</given-names></name><role>concep&#231;&#227;o ou desenho do estudo/pesquisa</role><role>an&#225;lise e/ou interpreta&#231;&#227;o dos dados</role><role>revis&#227;o final com participa&#231;&#227;o cr&#237;tica e intelectual no manuscrito</role><xref rid="aff4" ref-type="aff">I</xref></contrib></contrib-group><aff id="aff4">
<label>I</label>Universidade Federal do Tri&#226;ngulo Mineiro. Uberaba, Minas Gerais, Brazil</aff><aff id="aff5">
<label>II</label>Universidade Federal de Uberl&#226;ndia. Uberl&#226;ndia, Minas Gerais, Brazil</aff><aff id="aff6">
<label>III</label>Universidade Federal da Bahia. Vit&#243;ria da Conquista, Bahia, Brazil</aff><author-notes><corresp id="c2"><label>Autor Correspondente:</label> Maria Helena Barbosa, E-mail: <email>mhelena331@hotmail.com</email></corresp><fn fn-type="edited-by"><p><bold>EDITOR IN CHIEF:</bold> Antonio Jos&#233; de Almeida Filho</p></fn><fn fn-type="edited-by"><p><bold>ASSOCIATE EDITOR:</bold> Hugo Fernandes</p></fn></author-notes><abstract><title>RESUMO</title><sec><title>Objetivos:</title><p>adaptar para a l&#237;ngua portuguesa do Brasil e avaliar as propriedades clinim&#233;tricas do question&#225;rio <italic toggle="yes">International Pain Outcomes</italic>.</p></sec><sec><title>M&#233;todos:</title><p>pesquisa metodol&#243;gica, quantitativa, de valida&#231;&#227;o e adapta&#231;&#227;o transcultural de instrumento. Realizou-se tradu&#231;&#227;o; s&#237;ntese; avalia&#231;&#227;o pelo Comit&#234; de Ju&#237;zes; retrotradu&#231;&#227;o; consenso das vers&#245;es em ingl&#234;s e compara&#231;&#227;o com a vers&#227;o original; pr&#233;-teste (n=30); e valida&#231;&#227;o de propriedades m&#233;tricas (validade convergente, n=360; an&#225;lise de confiabilidade interobservadores, n=54; consist&#234;ncia interna, n=360).</p></sec><sec><title>Resultados:</title><p>a adapta&#231;&#227;o transcultural foi realizada satisfatoriamente, e considerou-se o instrumento validado quanto &#224; adequa&#231;&#227;o e aplica&#231;&#227;o. Na validade convergente, todas as correla&#231;&#245;es apresentaram p&#8804;0,001. Obteve se alfa de Cronbach de 0,796, Kappa=1,0 (itens dicot&#244;micos) e coeficiente de correla&#231;&#227;o intraclasse &gt; 0,999 (itens quantitativos).</p></sec><sec><title>Conclus&#245;es:</title><p>considerou-se o instrumento adequado quanto &#224; adapta&#231;&#227;o cultural, validado para portugu&#234;s do Brasil e confi&#225;vel para aplica&#231;&#227;o na assist&#234;ncia a pacientes em p&#243;s-operat&#243;rio.</p></sec></abstract><kwd-group><title>Descritores:</title><kwd>Dor P&#243;s-Operat&#243;ria</kwd><kwd>Manejo da Dor</kwd><kwd>Pesquisa Metodol&#243;gica em Enfermagem</kwd><kwd>Estudo de Valida&#231;&#227;o</kwd><kwd>Psicometria</kwd></kwd-group></front-stub><body><sec sec-type="intro"><title>INTRODU&#199;&#195;O</title><p>A dor p&#243;s-operat&#243;ria &#233; uma resposta fisiol&#243;gica ao dano tecidual causado pelo procedimento cir&#250;rgico, levando a uma experi&#234;ncia f&#237;sica e psicol&#243;gica desagrad&#225;vel<sup>(<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>)</sup>. Um grande n&#250;mero de pacientes vivencia essa dor a despeito das in&#250;meras diretrizes e protocolos baseados em evid&#234;ncias, interven&#231;&#245;es cl&#237;nicas focadas e avalia&#231;&#245;es padronizadas<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>)</sup>. Estima-se que 240 milh&#245;es de pacientes sejam submetidos a cirurgias por ano, dos quais 40% a 60% relatam dor clinicamente significativa<sup>(<xref rid="B5" ref-type="bibr">5</xref>-<xref rid="B8" ref-type="bibr">8</xref>)</sup>.</p><p>Quando mal administrada, a dor p&#243;s-operat&#243;ria pode levar ao risco aumentado de complica&#231;&#245;es respirat&#243;rias e cardiovasculares, acarretando eleva&#231;&#227;o dos custos do cuidado e efeitos negativos nos resultados da cirurgia e na satisfa&#231;&#227;o do paciente. Pode tamb&#233;m gerar complica&#231;&#245;es p&#243;s-operat&#243;rias, que, se n&#227;o forem resolvidas, aumentam a morbimortalidade e levam &#224; dor cr&#244;nica incapacitante<sup>(<xref rid="B9" ref-type="bibr">9</xref>-<xref rid="B11" ref-type="bibr">11</xref>)</sup>. O manejo adequado da dor n&#227;o apenas traz al&#237;vio, mas tamb&#233;m ajuda a acelerar a recupera&#231;&#227;o do paciente<sup>(<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</sup>.</p><p>Para proporcionar um manejo efetivo da dor, os profissionais de sa&#250;de devem avaliar a incid&#234;ncia de dor, sua intensidade em repouso e durante as atividades di&#225;rias (como caminhar, virar na cama e adormecer), verificar o protocolo de analgesia, monitorar os efeitos adversos dos medicamentos e o estado emocional (como ansiedade, raiva e medo) e avaliar a satisfa&#231;&#227;o do paciente, estabelecendo tamb&#233;m cuidados hol&#237;sticos no tratamento da dor<sup>(<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>Para auxiliar os profissionais de sa&#250;de a otimizar o gerenciamento da dor p&#243;s-operat&#243;ria na Europa, o PAIN OUT, projeto internacional financiado pela Comiss&#227;o Europeia<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup> em parceria com a Sociedade Americana de Dor, desenvolveu o question&#225;rio <italic toggle="yes">International Pain Outcomes</italic> (IPO). Trata-se de um instrumento que mede a variabilidade no atendimento, identifica as melhores pr&#225;ticas de manejo da dor e auxilia os profissionais na tomada de decis&#245;es<sup>(<xref rid="B17" ref-type="bibr">17</xref>)</sup>.</p><p>O question&#225;rio IPO foi desenvolvido para medir a qualidade do tratamento da dor p&#243;s operat&#243;ria durante as primeiras 24 horas de atendimento ao paciente no ambiente hospitalar, tendo sido adaptado para o ambiente p&#243;s-operat&#243;rio. A vers&#227;o em ingl&#234;s mais recente foi revisada e validada em 2010<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup>, e a qualidade psicom&#233;trica foi avaliada em 2013<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>.</p><p>A adapta&#231;&#227;o transcultural para o contexto brasileiro e a avalia&#231;&#227;o das suas propriedades m&#233;tricas possibilitar&#227;o a disponibiliza&#231;&#227;o de um instrumento para ajudar os profissionais de sa&#250;de a avaliar a intensidade e gravidade da dor e a capacidade funcional dos pacientes ap&#243;s a cirurgia. Essas aplica&#231;&#245;es proporcionar&#227;o um manejo eficaz da dor p&#243;s-operat&#243;ria e, consequentemente, a melhoria da qualidade da assist&#234;ncia e da seguran&#231;a do paciente bem como a redu&#231;&#227;o de custos operacionais para as institui&#231;&#245;es de sa&#250;de.</p></sec><sec><title>OBJETIVOS</title><p>Adaptar para a l&#237;ngua portuguesa do Brasil e avaliar as propriedades clinim&#233;tricas do question&#225;rio <italic toggle="yes">International Pain Outcomes</italic> (IPO).</p></sec><sec sec-type="methods"><title>M&#201;TODOS</title><sec><title>Aspectos &#233;ticos</title><p>Este estudo seguiu as recomenda&#231;&#245;es da Resolu&#231;&#227;o 466/2012 do Conselho Nacional de Sa&#250;de. Foi submetido e aprovado pelo Comite de &#201;tica em Pesquisa da Institui&#231;&#227;o sede do estudo. Todos os participantes receberam informa&#231;&#245;es verbais e escritas sobre os objetivos da pesquisa e assinaram o Termo de Consentimento Livre e Esclarecido (TCLE).</p></sec><sec><title>Desenho, per&#237;odo e local do estudo</title><p>Este estudo metodol&#243;gico e quantitativo foi realizado em duas etapas: adapta&#231;&#227;o transcultural e valida&#231;&#227;o psicom&#233;trica. A pesquisa foi realizada no setor de Cl&#237;nica Cir&#250;rgica de um hospital de ensino de grande porte, no interior do estado de Minas Gerais (MG). As coletas de dados foram realizadas de outubro a novembro de 2022 (pr&#233;-teste) e de fevereiro a agosto de 2023 (valida&#231;&#227;o psicom&#233;trica).</p></sec><sec><title>Popula&#231;&#227;o, amostra, crit&#233;rios de inclus&#227;o e exclus&#227;o</title><p>A popula&#231;&#227;o que realizou a adapta&#231;&#227;o transcultural foi composta de ju&#237;zes doutores que eram especialistas na tem&#225;tica e no m&#233;todo do estudo. Para o pr&#233;-teste e valida&#231;&#227;o psicom&#233;trica, a popula&#231;&#227;o-alvo foram os pacientes em p&#243;s-operat&#243;rio internados na Unidade de Cl&#237;nica Cir&#250;rgica da institui&#231;&#227;o sede do estudo.</p><p>Para o dimensionamento amostral da validade convergente, o c&#225;lculo do tamanho amostral considerou uma expectativa de correla&#231;&#227;o m&#237;nima de 0,2 entre o IPO e o Invent&#225;rio Breve de Dor (IBD)<sup>(<xref rid="B19" ref-type="bibr">19</xref>)</sup>, um poder estat&#237;stico de 95% a ser alcan&#231;ado e um n&#237;vel de signific&#226;ncia (alfa) de 0,005. Utilizando o aplicativo <italic toggle="yes">Power Analysis &amp; Sample Size</italic> - PASS, vers&#227;o 15, inserindo-se os par&#226;metros acima, obteve-se um tamanho amostral m&#237;nimo de 319 participantes. No entanto, a amostra final contou com 360 participantes.</p><p>O c&#225;lculo do tamanho amostral para a an&#225;lise de confiabilidade interobservador considerou um Coeficiente de Correla&#231;&#227;o Intraclasse (ICC) esperado de 0,8 entre os itens da vers&#227;o adaptada do IPO, admitindo-se que n&#227;o seja inferior a 0,6% para um poder de 90% e alfa igual a 0,05. Inserindo esses valores no aplicativo <italic toggle="yes">Power Analysis and Sample</italic>
<italic toggle="yes">Size</italic> (PASS), vers&#227;o 13, obteve-se um tamanho amostral m&#237;nimo de 54 pacientes.</p><p>Os crit&#233;rios de inclus&#227;o para os ju&#237;zes/peritos foram: brasileiros, especialistas na tem&#225;tica ou no m&#233;todo do estudo e enfermeiros cl&#237;nicos que atuavam diretamente na assist&#234;ncia ao paciente, todos com t&#237;tulo m&#237;nimo de doutor e dom&#237;nio da l&#237;ngua inglesa. Os dados relativos &#224; titula&#231;&#227;o do profissional foram verificados no Curr&#237;culo Lattes. Os peritos que n&#227;o devolveram os question&#225;rios respondidos no prazo de 30 dias foram considerados como perda de amostragem.</p><p>Inclu&#237;ram-se pacientes com idade igual ou superior a 18 anos, em p&#243;s-operat&#243;rio de cirurgias eletivas ou de emerg&#234;ncia, internados na Unidade de Cl&#237;nica Cir&#250;rgica da institui&#231;&#227;o sede do estudo durante o per&#237;odo de coleta dos dados, com tempo m&#237;nimo de 24 horas de p&#243;s-operat&#243;rio na unidade e que estavam conscientes o suficiente para responder ao question&#225;rio.</p><p>Exclu&#237;ram-se os pacientes que n&#227;o estavam em condi&#231;&#245;es de manter di&#225;logo com a pesquisadora.</p></sec><sec><title>Protocolo do estudo</title><p>O estudo foi conduzido ap&#243;s anu&#234;ncia da Dra. Claudia Weinmann, administradora do projeto PAIN OUT. No dia 23/04/2018, a referida autora enviou e-mail dando autoriza&#231;&#227;o para que o instrumento fosse submetido ao processo de adapta&#231;&#227;o cultural para o portugu&#234;s do Brasil.</p><p>O IPO cont&#233;m 18 itens prim&#225;rios e 3 secund&#225;rios. Os itens prim&#225;rios medem intensidade da dor; tempo de dor intensa; impacto da dor na atividade f&#237;sica, no sono e no afeto dos pacientes; efeitos colaterais adversos do tratamento; al&#237;vio da dor percebida pelos pacientes; n&#237;vel de participa&#231;&#227;o permitido no tratamento e satisfa&#231;&#227;o com o tratamento. Itens secund&#225;rios medem tanto o uso de abordagens n&#227;o farmacol&#243;gicas para reduzir a dor quanto a percep&#231;&#227;o da utilidade das informa&#231;&#245;es recebidas durante o tratamento. Com exce&#231;&#227;o dos itens que avaliam o tempo de dor intensa e a quantidade de al&#237;vio da dor recebida, ancorados entre 0% e 100%, os itens IPO prim&#225;rios s&#227;o medidos em uma escala de classifica&#231;&#227;o num&#233;rica de 0 a 10<sup>(<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>)</sup>.</p><p>Para a adapta&#231;&#227;o transcultural e valida&#231;&#227;o do instrumento, seguiram-se as orienta&#231;&#245;es propostas por Ferrer et al. (1996)<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup> e Beaton et al. (2007)<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>O instrumento foi traduzido por dois tradutores, brasileiros, com profici&#234;ncia do idioma ingl&#234;s, e um deles tinha conhecimento sobre a tem&#225;tica avaliada. As tradu&#231;&#245;es foram comparadas pelas pesquisadoras, e as discrep&#226;ncias ou ambiguidades existentes foram esclarecidas com os tradutores. Ap&#243;s an&#225;lise das vers&#245;es, foi realizada uma s&#237;ntese das tradu&#231;&#245;es, alcan&#231;ando-se, assim, o primeiro consenso da vers&#227;o em portugu&#234;s.</p><p>Em seguida, a vers&#227;o em portugu&#234;s foi avaliada por um comit&#234; de 11 ju&#237;zes (2 tradutores, 1 p&#243;s-doutora em aten&#231;&#227;o &#224; sa&#250;de, 5 doutoras em enfermagem, docentes pesquisadoras de institui&#231;&#245;es p&#250;blicas de ensino especialistas na tem&#225;tica e no m&#233;todo do estudo, e 3 doutores, enfermeiros cl&#237;nicos, que atuavam diretamente na assist&#234;ncia ao paciente, todos com dom&#237;nio da l&#237;ngua inglesa e com experi&#234;ncia na tem&#225;tica estudada). O objetivo era verificar as equival&#234;ncias sem&#226;ntica, idiom&#225;tica, cultural e conceitual dos itens, bem como a validade de face e conte&#250;do.</p><p>Os ju&#237;zes foram convidados via e-mail no qual constavam uma carta-convite e o TCLE com a descri&#231;&#227;o da finalidade e dos objetivos da pesquisa. Caso aceitasse participar, o convidado deveria enviar o TCLE assinado e digitalizado &#224;s pesquisadoras via e-mail. Depois de recebido o consentimento dos ju&#237;zes, as pesquisadoras encaminharam um segundo e-mail com o instrumento em sua vers&#227;o original e com a vers&#227;o portugu&#234;s, com fins de avalia&#231;&#227;o do instrumento. Depois, os ju&#237;zes devolveram o instrumento &#224;s pesquisadoras tamb&#233;m via e-mail.</p><p>Ap&#243;s a devolu&#231;&#227;o de todos os instrumentos pelos ju&#237;zes, a validade de conte&#250;do do instrumento foi verificada pelo consenso obtido em reuni&#227;o (via Google Meet) entre os autores, as pesquisadoras e os profissionais do Comit&#234; de Ju&#237;zes. Os ju&#237;zes solicitaram a manuten&#231;&#227;o do layout original e modifica&#231;&#245;es na tradu&#231;&#227;o do instrumento. Todas as altera&#231;&#245;es sugeridas por eles foram respeitadas, resultando na Vers&#227;o Portugu&#234;s Consensual 1(VPC1).</p><p>A VPC1 foi retrotraduzida do idioma portugu&#234;s para o ingl&#234;s por dois tradutores independentes, ingleses, com dom&#237;nio da l&#237;ngua portuguesa, que desconheciam o instrumento original e n&#227;o participaram da primeira etapa do processo de tradu&#231;&#227;o. Ap&#243;s a conclus&#227;o dessa etapa, duas novas vers&#245;es em ingl&#234;s foram produzidas. Elas foram comparadas pelas pesquisadoras; e, ap&#243;s an&#225;lise, obteve-se a s&#237;ntese da retrotradu&#231;&#227;o, que foi enviada para ser avaliada pelos autores do instrumento original.</p><p>O documento foi devolvido sem nenhuma modifica&#231;&#227;o. Assim, obteve-se a Vers&#227;o Portugu&#234;s Pr&#233;-Final do IPO, que foi submetida ao pr&#233;-teste. Para essa fase, foi selecionada uma amostra n&#227;o probabil&#237;stica de 30 pacientes, conforme recomendado pelo referencial metodol&#243;gico utilizado. Eles eram maiores de 18 anos, estavam em p&#243;s-operat&#243;rio de diferentes cirurgias, encontravam-se lotados nas diferentes unidades cir&#250;rgicas e de recupera&#231;&#227;o da institui&#231;&#227;o sede do estudo e tinham no m&#237;nimo 24 horas de p&#243;s-operat&#243;rio na unidade de interna&#231;&#227;o.</p><p>Entre outubro e novembro de 2022, ocorreu a coleta de dados por meio da autoaplica&#231;&#227;o da vers&#227;o adaptada do IPO e de um instrumento com dados de identifica&#231;&#227;o e de caracteriza&#231;&#227;o sociodemogr&#225;fica e cl&#237;nica dos participantes. Nessa etapa, ao responder o instrumento, o participante foi encorajado a sugerir melhoramentos quando considerasse apropriado.</p><p>A validade convergente foi avaliada mediante a aplica&#231;&#227;o independente e simult&#226;nea do IPO e IBD por dois avaliadores. A coleta de dados se deu no p&#243;s-operat&#243;rio (no m&#237;nimo, 24 horas) em uma amostra n&#227;o probabil&#237;stica de 360 pacientes. A an&#225;lise da evid&#234;ncia emp&#237;rica de validade convergente considerou as correla&#231;&#245;es entre os itens espec&#237;ficos que apresentaram a maior similaridade conceitual entre os dois instrumentos (IPO e IBD).</p><p>A avalia&#231;&#227;o da consist&#234;ncia interna dos itens da vers&#227;o adaptada foi determinada pelo c&#225;lculo do coeficiente de Kuder-Richardson (KR-20) para os itens dicot&#244;micos e coeficiente alfa de Cronbach original para itens quantitativos. Consideraram-se aceit&#225;veis valores entre 0,70 e 0,90<sup>(<xref rid="B22" ref-type="bibr">22</xref>)</sup>.</p><p>Para a avaliar a confiabilidade interobservadores, duas pesquisadoras aplicaram simultaneamente o question&#225;rio IPO em 54 pacientes, mantendo dist&#226;ncia entre elas e sem se comunicarem ou trocarem informa&#231;&#245;es durante a coleta. Utilizou-se o coeficiente Kappa para itens dicot&#244;micos e o ICC para itens quantitativos a fim de avaliar o grau de concord&#226;ncia entre os dois observadores.</p></sec></sec><sec sec-type="results"><title>RESULTADOS</title><sec><title>Adapta&#231;&#227;o transcultural para o portugu&#234;s do Brasil</title><p>Na fase de tradu&#231;&#227;o e s&#237;ntese, as diverg&#234;ncias encontradas nas tradu&#231;&#245;es relacionaram-se &#224;s palavras ou termos com significados semelhantes na l&#237;ngua portuguesa do Brasil (p.ex., cirurgia/procedimento cir&#250;rgico; administra&#231;&#227;o da dor/manejo da dor; fornecer/proporcionar).</p><p>Na fase de avalia&#231;&#227;o pelo Comit&#234; de Ju&#237;zes, os integrantes realizaram modifica&#231;&#245;es e melhorias relevantes. Ap&#243;s reuni&#227;o via Google Meet entre os autores, as pesquisadoras e os profissionais do Comit&#234;, todas as altera&#231;&#245;es sugeridas foram respeitadas e acatadas (<xref rid="t5" ref-type="table">Quadro 1</xref>).</p><table-wrap position="float" id="t5" orientation="portrait"><label>Quadro 1</label><caption><title>Descri&#231;&#227;o dos itens alterados ap&#243;s avalia&#231;&#227;o do Comit&#234; de Ju&#237;zes em compara&#231;&#227;o com a vers&#227;o traduzida do question&#225;rio <italic toggle="yes">International Pain Outcomes</italic>
</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1">VERS&#195;O TRADUZIDA</th><th align="left" colspan="2" rowspan="1">VERS&#195;O AP&#211;S AVALIA&#199;&#195;O DO COMIT&#202; DE JU&#205;ZES</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">QUESTION&#193;RIO SOBRE OS RESULTADOS DO PACIENTE</td><td align="left" colspan="2" rowspan="1">QUESTION&#193;RIO SOBRE OS RESULTADOS DO PACIENTE</td></tr><tr><td align="left" colspan="2" rowspan="1">C&#211;DIGO DO PACIENTE:</td><td align="left" colspan="2" rowspan="1">C&#211;DIGO DO PACIENTE</td></tr><tr><td align="left" colspan="2" rowspan="1">Caro senhor/senhora<break/>Agradecemos se voc&#234; puder participar da nossa pesquisa sobre como os pacientes se sentem ap&#243;s uma cirurgia. O objetivo da pesquisa &#233; melhorar a administra&#231;&#227;o da dor ap&#243;s cirurgias neste departamento.<break/>Sua participa&#231;&#227;o &#233; volunt&#225;ria, e a informa&#231;&#227;o que voc&#234; proporcionar vai tornar-se an&#244;nima assim que voc&#234; entregar este question&#225;rio. Isso significa que seu nome e outras formas de identifica&#231;&#227;o ser&#227;o apagados do question&#225;rio ap&#243;s a entrega e n&#227;o ser&#227;o inclu&#237;dos em quaisquer registros mantidos por n&#243;s.<break/>Suas respostas neste question&#225;rio n&#227;o ser&#227;o compartilhadas com sua equipe m&#233;dica ou de enfermagem.<break/>Sua equipe vai trat&#225;-lo(a) da mesma forma se voc&#234; escolher participar ou n&#227;o da pesquisa.<break/>Muito obrigado por considerar participar desta pesquisa.</td><td align="left" colspan="2" rowspan="1">Caro(a) Senhor/Senhora<break/>N&#243;s ficar&#237;amos muito gratos pela sua participa&#231;&#227;o em nossa pesquisa sobre como os pacientes se sentem ap&#243;s um procedimento cir&#250;rgico. O objetivo desta pesquisa &#233; melhorar o tratamento da dor p&#243;s-operat&#243;ria nesta unidade.<break/>Sua participa&#231;&#227;o &#233; volunt&#225;ria, e as informa&#231;&#245;es que voc&#234; fornecer ser&#227;o armazenadas de forma an&#244;nima assim que voc&#234; entregar este question&#225;rio. Isso significa que seu nome e outras formas de identifica&#231;&#227;o ser&#227;o apagados do question&#225;rio ap&#243;s a entrega e n&#227;o ser&#227;o inclu&#237;dos em nenhum dos nossos registros.<break/>Suas respostas neste question&#225;rio n&#227;o ser&#227;o compartilhadas com sua equipe m&#233;dica ou de enfermagem.<break/>A equipe de profissionais que cuida de voc&#234; vai trat&#225;-lo(a) da mesma forma, independentemente se voc&#234; escolher participar ou n&#227;o da pesquisa.<break/>Muito obrigado por considerar participar desta pesquisa.</td></tr><tr><td align="left" colspan="2" rowspan="1">As quest&#245;es a seguir s&#227;o sobre a dor que voc&#234; sentiu desde a cirurgia.</td><td align="left" colspan="2" rowspan="1">As quest&#245;es a seguir s&#227;o sobre a dor que voc&#234; sentiu desde a cirurgia.</td></tr><tr><td align="left" colspan="2" rowspan="1">P1. Nesta escala, por favor indique a pior dor que voc&#234; teve desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P1. Nesta escala, por favor assinale o n&#250;mero que representa a pior dor que voc&#234; sentiu desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">P2. Nesta escala, por favor indique a dor menos intensa que voc&#234; teve desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P2. Nesta escala, por favor assinale o n&#250;mero que representa a dor menos intensa que voc&#234; sentiu desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">P3. Com que frequ&#234;ncia voc&#234; teve dor intensa desde a cirurgia?<break/>Por favor, circule sua melhor estimativa da porcentagem de tempo durante o qual voc&#234; teve dor intensa:</td><td align="left" colspan="2" rowspan="1">P3. Com que frequ&#234;ncia voc&#234; sentiu dor intensa desde a cirurgia?<break/>Por favor, assinale a porcentagem que mais se aproxima do tempo durante o qual voc&#234; sentiu dor intensa:</td></tr><tr><td align="left" rowspan="1" colspan="1">Nunca tive dor intensa</td><td align="left" rowspan="1" colspan="1">Dor intensa o tempo todo</td><td align="left" rowspan="1" colspan="1">Nunca senti dor intensa</td><td align="left" rowspan="1" colspan="1">Dor intensa o tempo todo</td></tr><tr><td align="left" colspan="2" rowspan="1">P4. Circule o n&#250;mero que melhor descreve o quanto, desde a cirurgia, a dor interferiu ou o(a) impediu de ...</td><td align="left" colspan="2" rowspan="1">P4. Assinale o n&#250;mero que melhor descreve o quanto, ap&#243;s a cirurgia, a dor interferiu ou o(a) impediu de...</td></tr><tr><td align="left" colspan="2" rowspan="1">a. fazer atividades na cama como virar, sentar, mudar de posi&#231;&#227;o:</td><td align="left" colspan="2" rowspan="1">a. realizar atividades na cama, tais como virar, sentar, mudar de posi&#231;&#227;o:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">b. respirar profundamente ou tossir:</td><td align="left" colspan="2" rowspan="1">b. respirar profundamente ou tossir:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">c. dormir:</td><td align="left" colspan="2" rowspan="1">c. dormir:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">d. Voc&#234; saiu da cama desde a cirurgia?</td><td align="left" colspan="2" rowspan="1">d. Voc&#234; conseguiu se levantar da cama ap&#243;s a cirurgia?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Se sim, quanto a dor o(a) atrapalhou ou impediu de fazer atividades fora da cama como caminhar, sentar-se em uma cadeira, ficar em p&#233; &#224; beira da pia:</td><td align="left" colspan="2" rowspan="1">Se sim, quanto a dor o(a) atrapalhou ou impediu de fazer atividades fora da cama, tais como caminhar, sentar-se em uma cadeira, ir ao banheiro:</td></tr><tr><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td><td align="left" rowspan="1" colspan="1">N&#227;o interferiu</td><td align="left" rowspan="1" colspan="1">Interferiu totalmente</td></tr><tr><td align="left" colspan="2" rowspan="1">P5. A dor pode afetar o humor e as emo&#231;&#245;es.</td><td align="left" colspan="2" rowspan="1">P5. A dor pode influenciar o nosso humor e as nossas emo&#231;&#245;es.</td></tr><tr><td align="left" colspan="2" rowspan="1">Nesta escala, por favor circule o n&#250;mero que melhor mostra o quanto, desde a cirurgia, a dor fez com que voc&#234; se sentisse...</td><td align="left" colspan="2" rowspan="1">Nesta escala, por favor assinale o n&#250;mero que melhor descreve o quanto, ap&#243;s a sua cirurgia, a dor fez com que voc&#234; se sentisse...</td></tr><tr><td align="left" colspan="2" rowspan="1">a. ansioso(a)</td><td align="left" colspan="2" rowspan="1">a. ansioso(a)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td></tr><tr><td align="left" colspan="2" rowspan="1">b. incapaz</td><td align="left" colspan="2" rowspan="1">b. desamparado</td></tr><tr><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Extremamente</td></tr><tr><td align="left" colspan="2" rowspan="1">P6. Voc&#234; teve algum dos seguintes efeitos colaterais desde a cirurgia?</td><td align="left" colspan="2" rowspan="1">P6. Voc&#234; percebeu algum dos seguintes efeitos colaterais desde a cirurgia?</td></tr><tr><td align="left" colspan="2" rowspan="1">Por favor, circule &#8220;0&#8221; se n&#227;o teve; se teve, circule o n&#250;mero que melhor representa a intensidade de cada um:</td><td align="left" colspan="2" rowspan="1">Por favor, assinale &#8220;0&#8221; se n&#227;o sentiu; se sentiu, assinale o n&#250;mero que melhor representa a intensidade de cada um:</td></tr><tr><td align="left" colspan="2" rowspan="1">a. N&#225;usea</td><td align="left" colspan="2" rowspan="1">a. N&#225;usea</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">b. Sonol&#234;ncia</td><td align="left" colspan="2" rowspan="1">b. Sonol&#234;ncia</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">c. Coceira</td><td align="left" colspan="2" rowspan="1">c. Coceira</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">d. Tontura</td><td align="left" colspan="2" rowspan="1">d. Tonturas</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td><td align="left" rowspan="1" colspan="1">Nenhuma</td><td align="left" rowspan="1" colspan="1">Severa</td></tr><tr><td align="left" colspan="2" rowspan="1">P7. Desde a cirurgia, quanto al&#237;vio para a dor voc&#234; recebeu?</td><td align="left" colspan="2" rowspan="1">P7. Desde a cirurgia, quanto al&#237;vio para a dor voc&#234; sentiu?</td></tr><tr><td align="left" colspan="2" rowspan="1">Por favor, circule a porcentagem que melhor representa quanto al&#237;vio para dor voc&#234; recebeu de todos os tratamentos para dor juntos (tratamentos medicamentosos ou n&#227;o):</td><td align="left" colspan="2" rowspan="1">Por favor, assinale a porcentagem que melhor representa o n&#237;vel de al&#237;vio para dor sentido ap&#243;s todos os tratamentos para dor utilizados (tratamentos medicamentosos e n&#227;o medicamentosos):</td></tr><tr><td align="left" rowspan="1" colspan="1">Nenhum al&#237;vio</td><td align="left" rowspan="1" colspan="1">Al&#237;vio completo</td><td align="left" rowspan="1" colspan="1">Nenhum al&#237;vio</td><td align="left" rowspan="1" colspan="1">Al&#237;vio completo</td></tr><tr><td align="left" colspan="2" rowspan="1">P8. Voc&#234; gostaria de ter recebido MAIS tratamento para a dor do que recebeu?</td><td align="left" colspan="2" rowspan="1">P8. Voc&#234; gostaria de ter recebido MAIS tratamento para a dor do que recebeu?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">P9. Voc&#234; recebeu alguma informa&#231;&#227;o sobre suas op&#231;&#245;es de tratamento para a dor?</td><td align="left" colspan="2" rowspan="1">P9. Voc&#234; recebeu alguma informa&#231;&#227;o sobre as suas op&#231;&#245;es de tratamento para a dor?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">P10. Voc&#234; foi autorizado a participar das decis&#245;es sobre seu tratamento para a dor tanto quanto gostaria?</td><td align="left" colspan="2" rowspan="1">P10. Voc&#234; participou das decis&#245;es sobre seu tratamento para a dor tanto quanto gostaria?</td></tr><tr><td align="left" rowspan="1" colspan="1">De forma alguma</td><td align="left" rowspan="1" colspan="1">Bastante</td><td align="left" rowspan="1" colspan="1">Nem um pouco</td><td align="left" rowspan="1" colspan="1">Bastante</td></tr><tr><td align="left" colspan="2" rowspan="1">P11. Circule o n&#250;mero que melhor representa o qu&#227;o satisfeito(a) voc&#234; est&#225; com os resultados do seu tratamento para dor desde a cirurgia:</td><td align="left" colspan="2" rowspan="1">P11. Assinale o n&#250;mero que melhor representa o qu&#227;o satisfeito(a) voc&#234; est&#225; com os resultados do seu tratamento para dor desde a cirurgia:</td></tr><tr><td align="left" rowspan="1" colspan="1">Extremamente insatisfeito</td><td align="left" rowspan="1" colspan="1">Extremamente satisfeito</td><td align="left" rowspan="1" colspan="1">Extremamente insatisfeito</td><td align="left" rowspan="1" colspan="1"> Extremamente satisfeito</td></tr><tr><td align="left" colspan="2" rowspan="1">P12. Voc&#234; usou ou recebeu algum m&#233;todo n&#227;o medicamentoso para al&#237;vio da dor?</td><td align="left" colspan="2" rowspan="1">P12. Voc&#234; solicitou ou recebeu algum tratamento n&#227;o medicamentoso para al&#237;vio da dor?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Se sim, marque todos que se aplicam:</td><td align="left" colspan="2" rowspan="1">Se sim, marque todos que se aplicam:</td></tr><tr><td align="left" colspan="2" rowspan="1">Bolsa de gelo Medita&#231;&#227;o<break/>Respirar profundamente Calor<break/>Acupuntura Prece Conversas com a equipe m&#233;dica<break/>Caminhada Massagem Conversas com amigos ou familiares<break/>Relaxamento Imagens ou visualiza&#231;&#227;o</td><td align="left" colspan="2" rowspan="1">Bolsa de gelo Medita&#231;&#227;o Respira&#231;&#227;o profunda Calor<break/>Acupuntura Ora&#231;&#245;es Conversas com a equipe m&#233;dica<break/>Caminhada Massagem Conversas com amigos ou familiares<break/>Relaxamento Imagens ou visualiza&#231;&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">TENS (Neuroestimula&#231;&#227;o El&#233;trica Transcut&#226;nea)</td><td align="left" colspan="2" rowspan="1">TENS (Neuroestimula&#231;&#227;o El&#233;trica Transcut&#226;nea)</td></tr><tr><td align="left" colspan="2" rowspan="1">Distra&#231;&#245;es (como ver TV, ouvir m&#250;sica, ler etc.)</td><td align="left" colspan="2" rowspan="1">Distra&#231;&#245;es (como ver TV, ouvir m&#250;sica, ler etc.)</td></tr><tr><td align="left" colspan="2" rowspan="1">Outras (por favor, descreva):</td><td align="left" colspan="2" rowspan="1">Outras (por favor, descreva):</td></tr><tr><td align="left" colspan="2" rowspan="1">P13. Voc&#234; teve alguma condi&#231;&#227;o de dor persistente por tr&#234;s meses ou mais antes de vir ao hospital para a cirurgia?</td><td align="left" colspan="2" rowspan="1">P13. Antes de vir ao hospital para esta cirurgia voc&#234; sentiu alguma condi&#231;&#227;o de dor persistente por tr&#234;s meses ou mais?</td></tr><tr><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td><td align="left" rowspan="1" colspan="1">Sim</td><td align="left" rowspan="1" colspan="1">N&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">a. Se sim, qu&#227;o intensa foi a dor na maior parte do tempo?<break/>Por favor, circule o n&#250;mero que indica isso.</td><td align="left" colspan="2" rowspan="1">a. Se sim, qual a intensidade da dor na maior parte do tempo? Por favor, assinale o n&#250;mero que indica esta intensidade.</td></tr><tr><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td><td align="left" rowspan="1" colspan="1">Sem dor</td><td align="left" rowspan="1" colspan="1">Pior dor poss&#237;vel</td></tr><tr><td align="left" colspan="2" rowspan="1">b. Se teve dor, onde esta dor persistente estava localizada?</td><td align="left" colspan="2" rowspan="1">b. Se sentiu dor, onde esta dor persistente estava localizada?</td></tr><tr><td align="left" colspan="2" rowspan="1">Local da cirurgia Outro local Ambos (local da cirurgia e outro local)</td><td align="left" colspan="2" rowspan="1">Local da cirurgia Outro local Ambos (local da cirurgia e outro local)</td></tr><tr><td align="left" colspan="2" rowspan="1">Obrigado por seu tempo e contribui&#231;&#227;o</td><td align="left" colspan="2" rowspan="1">Obrigado por seu tempo e sua participa&#231;&#227;o</td></tr><tr><td align="left" colspan="2" rowspan="1">Para ser preenchido pelo assistente de pesquisa<break/>C&#243;digo do assistente de pesquisa:<break/>Paciente foi entrevistado: Sim N&#227;o<break/>Se sim, por favor assinale o(s) motivo(s):<break/>Doente/fraco demais<break/>Sentia muita dor<break/>Necessitava de ajuda<break/>N&#227;o entendia as escalas<break/>Motivos t&#233;cnicos (paciente estava sem &#243;culos/&#233; cego; n&#227;o consegue sentar-se; &#233; analfabeto; bra&#231;o estava engessado etc.)</td><td align="left" colspan="2" rowspan="1">Para ser preenchido pelo assistente de pesquisa<break/>C&#243;digo do assistente de pesquisa:<break/>Paciente foi entrevistado? Sim N&#227;o<break/>Se sim, por favor assinale o(s) motivo(s):<break/>Doente/fraco demais <break/>Sentia muita dor<break/>Necessitava de ajuda<break/>N&#227;o entendia as escalas<break/>Motivos t&#233;cnicos (paciente estava sem &#243;culos/&#233; cego; n&#227;o consegue sentar-se; &#233; analfabeto; bra&#231;o estava engessado etc.)</td></tr></tbody></table></table-wrap><p>Na retrotradu&#231;&#227;o, todas as diverg&#234;ncias encontradas foram consideradas palavras sin&#244;nimas, e as pesquisadoras optaram pelos termos que julgaram mais usuais na l&#237;ngua portuguesa do Brasil.</p></sec><sec><title>Pr&#233;-teste</title><p>Um total de 30 pacientes participou do pr&#233;-teste. A maioria dos participantes (23; 76,6%) eram do sexo feminino, 22 (70,2%) tinham entre 18 e 39 anos, e 8 (29,8%) tinham entre 40 e 60 anos; 26 (86%) eram casados; 19 (63,2%) tinham ensino m&#233;dio completo, sendo 11 (36,8%) com ensino superior. No tocante &#224; ocupa&#231;&#227;o, 21 (70%) estavam empregados.</p><p>Quanto aos dados cl&#237;nicos, a maioria (19; 63,2 %) dos participantes realizou cirurgia de m&#233;dio a grande porte, 11 (36,3%) apresentaram hipertens&#227;o arterial como comorbidade, 19 (63,2%) receberam anestesia geral, e nenhum participante teve complica&#231;&#245;es na sala de opera&#231;&#245;es. Todos os participantes receberam medica&#231;&#227;o analg&#233;sica na sala de opera&#231;&#245;es e mantiveram essa medica&#231;&#227;o de hor&#225;rio nas 24 horas seguintes &#224; cirurgia.</p><p>Todos os participantes do pr&#233;-teste disseram compreender as quest&#245;es do instrumento de forma clara. Com esse resultado, considerou-se o instrumento validado quanto &#224; adequa&#231;&#227;o e aplica&#231;&#227;o, gerando assim a vers&#227;o final do question&#225;rio ap&#243;s o pr&#233;-teste, denominada <italic toggle="yes">International Pain Outcomes</italic> (IPO) &#8211; vers&#227;o portugu&#234;s do Brasil (<xref rid="f2" ref-type="fig">Figura 1</xref>).</p><p>
<fig position="float" id="f2" orientation="portrait"><label>Figura 1</label><caption><title>
<italic toggle="yes">International Pain Outcomes</italic> &#8211; vers&#227;o portugu&#234;s do Brasil</title></caption><graphic position="float" orientation="portrait" xlink:href="0034-7167-reben-78-03-e20240346-gf02.jpg"/></fig>
</p></sec><sec><title>Valida&#231;&#227;o psicom&#233;trica</title><p>Dos 360 participantes, 208 (57,8%) eram homens. A m&#233;dia de idade foi de 55,88 anos (&#177;16,37). O tempo m&#233;dio de cirurgia foi de 123,44 minutos (&#177;84,39). Os resultados evidenciaram que a correla&#231;&#227;o forte e muito forte foram indicadores de validade convergente em itens semelhantes entre os instrumentos analisados. Todas as correla&#231;&#245;es entre os respectivos itens em ambas as escalas foram estatisticamente significantes (p &#8804; 0,001), demonstrando que o IPO &#233; capaz de avaliar a dor nos pacientes na mesma medida que o IBD, instrumento j&#225; validado e utilizado na pr&#225;tica cl&#237;nica (<xref rid="t6" ref-type="table">Tabela 1</xref>).</p><table-wrap position="float" id="t6" orientation="portrait"><label>Tabela 1</label><caption><title>Validade convergente (N = 360) considerando o Invent&#225;rio Breve de Dor, Uberaba, Minas Gerais, Brasil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">IPO</th><th align="center" colspan="2" rowspan="1">IBD</th></tr><tr><th align="center" rowspan="1" colspan="1">R</th><th align="center" rowspan="1" colspan="1">Valor de <italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">N&#250;mero que representa a pior dor desde a cirurgia</td><td align="center" colspan="2" rowspan="1">N&#250;mero que melhor descreve a pior dor nas &#250;ltimas 24 h</td></tr><tr><td align="center" rowspan="1" colspan="1">0,933</td><td align="center" rowspan="1" colspan="1">&#8804; 0,001</td></tr><tr><td align="left" rowspan="2" colspan="1">N&#250;mero que representa a dor menos intensa desde a cirurgia</td><td align="center" colspan="2" rowspan="1">N&#250;mero que melhor descreve a dor mais fraca nas &#250;ltimas 24 h</td></tr><tr><td align="center" rowspan="1" colspan="1">0,867</td><td align="center" rowspan="1" colspan="1">&#8804; 0,001</td></tr><tr><td align="left" rowspan="2" colspan="1">N&#250;mero que representa o quanto a dor interferiu nas atividades fora da cama</td><td align="center" colspan="2" rowspan="1">N&#250;mero que melhor descreve o quanto a dor interferiu em sua habilidade de caminhar</td></tr><tr><td align="center" rowspan="1" colspan="1">0,806</td><td align="center" rowspan="1" colspan="1">&#8804; 0,001</td></tr><tr><td align="left" rowspan="2" colspan="1">N&#250;mero que representa o quanto a dor interferiu no sono</td><td align="center" colspan="2" rowspan="1">N&#250;mero que melhor descreve o quanto a dor interferiu em seu sono</td></tr><tr><td align="center" rowspan="1" colspan="1">0,786</td><td align="center" rowspan="1" colspan="1">&#8804; 0,001</td></tr><tr><td align="left" rowspan="2" colspan="1">N&#237;vel de al&#237;vio da dor ap&#243;s tratamentos utilizados</td><td align="center" colspan="2" rowspan="1">Melhora proporcionada pelos tratamentos ou medica&#231;&#245;es</td></tr><tr><td align="center" rowspan="1" colspan="1">0,809</td><td align="center" rowspan="1" colspan="1">&#8804; 0,001</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>
<italic toggle="yes">IPO &#8211; International Pain Outcomes; IBD &#8211; Invent&#225;rio Breve de Dor.</italic>
</p></fn></table-wrap-foot></table-wrap><p>A an&#225;lise de consist&#234;ncia interna foi avaliada por meio do coeficiente de Kuder-Richardson (KR-20) para itens dicot&#244;micos e alfa de Cronbach para itens quantitativos. Para as escalas de 0 a 10, obteve-se um alfa de 0,796, dentro dos valores considerados aceit&#225;veis para a confiabilidade do instrumento.</p><p>Tamb&#233;m se considerou a an&#225;lise de confiabilidade interobservadores avaliada por meio do Kappa, assim como o ICC entre os observadores para cada item do instrumento. Todos os resultados de Kappa (<xref rid="t7" ref-type="table">Tabela 2</xref>) foram iguais a 1, e o ICC foi acima de 0,999, ambos os quais indicam boa confiabilidade interobservador (<xref rid="t8" ref-type="table">Tabela 3</xref>).</p><table-wrap position="float" id="t7" orientation="portrait"><label>Tabela 2</label><caption><title>Resultados da confiabilidade interobservadores (n = 54) por meio do coeficiente de Kappa, Uberaba, Minas Gerais, Brasil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" colspan="1">Itens</th><th align="center" colspan="4" rowspan="1">Observador 1</th><th align="center" colspan="4" rowspan="1">Observador 2</th><th align="center" rowspan="3" colspan="1">Propor&#231;&#227;o da concord&#226;ncia (%)</th><th align="center" rowspan="3" colspan="1">Kappa</th><th align="center" rowspan="3" colspan="1">Valor de <italic toggle="yes">p</italic>
</th></tr><tr><th align="center" colspan="2" rowspan="1">Sim</th><th align="center" colspan="2" rowspan="1">N&#227;o</th><th align="center" colspan="2" rowspan="1">Sim</th><th align="center" colspan="2" rowspan="1">N&#227;o</th></tr><tr><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">J&#225; conseguiu levantar da cama?</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">88,9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">11,11</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">88,9</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">11,11</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Gostaria de ter recebido mais tratamento do que recebeu?</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18,5</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">81,5</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18,6</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">81,4</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Recebeu informa&#231;&#245;es sobre suas op&#231;&#245;es de tratamento para dor?</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">38,9</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">61,1</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">38,9</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">61,1</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Tratamento n&#227;o medicamentoso</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">9,3</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">90,7</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">9,3</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">90,7</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Antes dessa cirurgia, apresentou alguma dor persistente por tr&#234;s meses ou mais?</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">42,6</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">57,4</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">42,6</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">57,4</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t8" orientation="portrait"><label>Tabela 3</label><caption><title>Resultados da confiabilidade interobservadores (n = 54) por meio do Coeficiente de Correla&#231;&#227;o Intraclasse, Uberaba, Minas Gerais, Brasil, 2023</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="2" colspan="1">Itens</th><th align="center" colspan="5" rowspan="1">Observador 1</th><th align="center" colspan="6" rowspan="1">Observador 2</th><th align="center" rowspan="2" colspan="1">Valor de <italic toggle="yes">p</italic>
</th></tr><tr><th align="center" rowspan="1" colspan="1">M&#237;n.</th><th align="center" rowspan="1" colspan="1">M&#225;x.</th><th align="center" rowspan="1" colspan="1">M&#233;dia</th><th align="center" rowspan="1" colspan="1">Mediana</th><th align="center" rowspan="1" colspan="1">DP</th><th align="center" rowspan="1" colspan="1">M&#237;n.</th><th align="center" rowspan="1" colspan="1">M&#225;x.</th><th align="center" rowspan="1" colspan="1">M&#233;dia</th><th align="center" rowspan="1" colspan="1">Mediana</th><th align="center" rowspan="1" colspan="1">DP</th><th align="center" rowspan="1" colspan="1">ICC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Pior dor</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5,65</td><td align="center" rowspan="1" colspan="1">6,5</td><td align="center" rowspan="1" colspan="1">3,43</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5,65</td><td align="center" rowspan="1" colspan="1">6,5</td><td align="center" rowspan="1" colspan="1">3,43</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Menor dor</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,41</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2,51</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,41</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2,51</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Frequ&#234;ncia de dor intensa</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">36,85</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">35,97</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">36,85</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">35,97</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interferiu em realizar atividades na cama</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,89</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4,17</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,89</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4,17</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interferiu em respirar ou tossir</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3,96</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4,34</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">3,96</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">4,34</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interferiu em dormir</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,13</td><td align="center" rowspan="1" colspan="1">4,5</td><td align="center" rowspan="1" colspan="1">4,15</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,2</td><td align="center" rowspan="1" colspan="1">4,5</td><td align="center" rowspan="1" colspan="1">4,20</td><td align="center" rowspan="1" colspan="1">0,99</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Fez com que se sentisse ansioso</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,33</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4,05</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,33</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4,05</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Fez com que se sentisse desamparado</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,28</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,61</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,28</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,61</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Teve n&#225;usea como efeito colateral</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,47</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,22</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,47</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Teve sonol&#234;ncia como efeito colateral</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,06</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4,11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4,06</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4,11</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Teve coceira como efeito colateral</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,02</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,29</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,02</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,29</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Teve tontura como efeito colateral</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,57</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,44</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2,57</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3,44</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Al&#237;vio da dor com tratamentos utilizados</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">36,70</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">36,70</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Participa&#231;&#227;o nas decis&#245;es do tratamento para dor</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5,85</td><td align="center" rowspan="1" colspan="1">9,5</td><td align="center" rowspan="1" colspan="1">4,64</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5,85</td><td align="center" rowspan="1" colspan="1">9,5</td><td align="center" rowspan="1" colspan="1">4,64</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr><tr><td align="left" rowspan="1" colspan="1">Satisfa&#231;&#227;o com os resultados de tratamento para dor</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9,33</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1,64</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">9,33</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">1,64</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&lt; 0,001</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSS&#195;O</title><p>Adaptar e validar os instrumentos para avalia&#231;&#227;o de resultados dispon&#237;veis na literatura internacional torna-se uma op&#231;&#227;o vi&#225;vel na medida em que permite economizar tempo e recursos bem como comparar os resultados das pesquisas com estudos realizados entre os pa&#237;ses ou mesmo entre pessoas de origens distintas<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>.</p><p>A adapta&#231;&#227;o transcultural do IPO para uso no Brasil ocorreu de forma sistematizada e seguiu todas as etapas internacionais preconizadas para adapta&#231;&#227;o cultural de instrumentos de medida, de acordo com o m&#233;todo descrito por Ferrer et al. (1996)<sup>(<xref rid="B20" ref-type="bibr">20</xref>)</sup> e Beaton et al. (2007)<sup>(<xref rid="B21" ref-type="bibr">21</xref>)</sup>. Foram realizadas modifica&#231;&#245;es respeitando as particularidades da popula&#231;&#227;o-alvo durante a adapta&#231;&#227;o transcultural, para que o instrumento seja bem compreendido e aplicado de modo eficaz. Isso porque, segundo a literatura, uma tradu&#231;&#227;o culturalmente equivalente &#233; importante para que os termos utilizados no instrumento sejam coerentes com a realidade vivenciada pela popula&#231;&#227;o-alvo, dentro de seu contexto cultural. Caso esses termos se encontrem fora do contexto ou da viv&#234;ncia daquela popula&#231;&#227;o, eles devem ser modificados<sup>(<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>)</sup>.</p><p>Neste estudo, as altera&#231;&#245;es nos itens da vers&#227;o traduzida foram guiadas pelas sugest&#245;es dos ju&#237;zes e pautadas nos princ&#237;pios que reafirmam a import&#226;ncia da autonomia das pessoas que passaram por procedimentos cir&#250;rgicos e vivenciaram a dor p&#243;s-operat&#243;ria. A aplica&#231;&#227;o do pr&#233;-teste sustentou o objetivo de assegurar a compreens&#227;o e a escolha precisa das palavras componentes da vers&#227;o traduzida, garantindo que sejam entendidas com clareza pela popula&#231;&#227;o-alvo e preservando a originalidade do instrumento de origem<sup>(<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>)</sup>.</p><p>Quanto &#224; validade convergente, os resultados indicaram uma correla&#231;&#227;o de forte a muito forte entre os itens espec&#237;ficos que apresentaram maior similaridade conceitual entre os dois instrumentos, demonstrando que o IPO &#233; capaz de avaliar a dor nos pacientes na mesma medida que o IBD, instrumento j&#225; validado e utilizado na pr&#225;tica avaliada. J&#225; Erden et al.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>, ao conjugarem o question&#225;rio IPO com o IBD na valida&#231;&#227;o da vers&#227;o turca do IPO, encontraram correla&#231;&#227;o positiva moderada entre os itens similares das duas escalas.</p><p>Na an&#225;lise da consist&#234;ncia interna, o alfa de Cronbach foi de 0,796. O valor se assemelha ao encontrado em estudo de valida&#231;&#227;o do instrumento original<sup>(<xref rid="B18" ref-type="bibr">18</xref>)</sup>, em que o question&#225;rio IPO foi aplicado a 9.727 pacientes em dez idiomas, abarcando oito pa&#237;ses europeus e Israel. O alfa alcan&#231;ou o n&#237;vel geral alto (0,86), e a qualidade psicom&#233;trica do instrumento foi considerada satisfat&#243;ria.</p><p>No estudo de valida&#231;&#227;o da vers&#227;o turca do IPO, o question&#225;rio foi aplicado a 250 pacientes cir&#250;rgicos (98 homens, 152 mulheres) entre janeiro de 2015 e janeiro de 2016. Alinhado com os nossos resultados, a consist&#234;ncia interna apresentou alfa de Cronbach de 0,88. Os autores conclu&#237;ram que a vers&#227;o turca do IPO &#233; confi&#225;vel e v&#225;lida para medir e avaliar a qualidade do tratamento da dor p&#243;s-operat&#243;ria na popula&#231;&#227;o turca<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>Em contrapartida, o estudo de valida&#231;&#227;o da vers&#227;o dinamarquesa do IPO avaliou 56 pacientes com dor abdominal aguda, realizando os testes de consist&#234;ncia interna por meio de avalia&#231;&#227;o dos itens do instrumento. Os resultados mostraram alfa de Cronbach &#8805; 0,7 para as subescalas de dor, satisfa&#231;&#227;o, atividade e emo&#231;&#227;o; 0,69 para a subescala de satisfa&#231;&#227;o na &#8220;interna&#231;&#227;o hospitalar&#8221;; &#8804; 0,7 para a subescala de seguran&#231;a; e &#8804; 0,62 para a subescala de barreira do paciente. O estudo n&#227;o apresentou alfa de Cronbach para a escala total<sup>(<xref rid="B26" ref-type="bibr">26</xref>)</sup>.</p><p>Ainda, no estudo de valida&#231;&#227;o do IPO para 268 pacientes dinamarqueses e 311 pacientes australianos, os resultados demonstraram que a consist&#234;ncia interna foi insatisfat&#243;ria, com alfa igual a 0,54 para os dinamarqueses e 0,63 para os australianos<sup>(<xref rid="B27" ref-type="bibr">27</xref>)</sup>. Corroborando esses resultados, o question&#225;rio usado na valida&#231;&#227;o da vers&#227;o islandesa foi aplicado em 143 pacientes internados nas enfermarias em um hospital universit&#225;rio, e os resultados apresentaram alfa de Cronbach igual a 0,42 para a escala total<sup>(<xref rid="B28" ref-type="bibr">28</xref>)</sup>.</p><p>O grau de concord&#226;ncia entre os observadores quanto aos escores do instrumento foi verificado neste estudo por meio da an&#225;lise interobservadores, avaliada pelo Kappa e pelo ICC. Todos os resultados de Kappa foram iguais a 1, e o ICC apresentou resultados acima de 0,999, indicando alta confiabilidade. A abordagem adotada neste estudo para avaliar a confiabilidade de um question&#225;rio ap&#243;s a adapta&#231;&#227;o transcultural n&#227;o foi usada na valida&#231;&#227;o do instrumento original, entretanto atingiu resultados estat&#237;sticos satisfat&#243;rios.</p><p>Medi&#231;&#245;es com instrumentos v&#225;lidos e confi&#225;veis s&#227;o essenciais para explorar estrat&#233;gias eficazes de tratamento da dor e avaliar a melhoria da qualidade no manejo da dor na pr&#225;tica cl&#237;nica. A aplica&#231;&#227;o do IPO para registrar e avaliar a dor p&#243;s-operat&#243;ria bem como otimizar sua gest&#227;o &#233; relatada nos estudos internacionais descritos a seguir.</p><p>Visando realizar projetos de melhoria da qualidade no manejo da dor em cada pa&#237;s, o grupo PAIN OUT usou o IPO para avaliar o manejo da dor p&#243;s-operat&#243;ria em 10.415 pacientes de 105 enfermarias cir&#250;rgicas, em 64 hospitais do M&#233;xico, China e oito pa&#237;ses europeus. De todos os pacientes, 48,7% relataram pior dor com escore entre 7 e 10, enquanto 24,3% relataram sentir dor intensa por mais de 50% do tempo desde a cirurgia e 34% relataram classifica&#231;&#245;es severas de interfer&#234;ncia funcional e emocional relacionadas &#224; dor. Os resultados demonstraram que a qualidade no manejo da dor p&#243;s-operat&#243;ria nos pa&#237;ses avaliados necessita melhorias<sup>(<xref rid="B29" ref-type="bibr">29</xref>)</sup>.</p><p>Para relatar o desenvolvimento e a viabilidade do projeto PAIN OUT, Zaslansky et al. (2015)<sup>(<xref rid="B30" ref-type="bibr">30</xref>)</sup> empregaram o question&#225;rio IPO para avaliar, no primeiro dia de p&#243;s-operat&#243;rio, 6.347 pacientes adultos submetidos a cirurgia ortop&#233;dica ou geral em onze centros m&#233;dicos na Europa e em Israel. Os resultados demonstraram que o projeto PAIN OUT oferece aos profissionais da sa&#250;de instrumentos padronizados e validados para medi&#231;&#227;o e feedback da qualidade dos resultados, apoiando-os no processo de tomada de decis&#227;o para otimizar o manejo da dor de seus pacientes.</p><p>Desse panorama, observa-se que avalia&#231;&#245;es regulares da dor s&#227;o recomendadas ap&#243;s a cirurgia para que haja um aumento de conscientiza&#231;&#227;o dos profissionais de sa&#250;de, permitindo que eles forne&#231;am abordagens analg&#233;sicas espec&#237;ficas e eficazes ao paciente<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>.</p><p>Considerando os objetivos do presente estudo, o processo de adapta&#231;&#227;o transcultural e a valida&#231;&#227;o psicom&#233;trica do question&#225;rio <italic toggle="yes">International Pain Outcomes</italic> (IPO): vers&#227;o portugu&#234;s do Brasil foram realizados de forma adequada e a validade est&#225; assegurada.</p><sec><title>Limita&#231;&#245;es do estudo</title><p>Considera-se como limita&#231;&#227;o deste estudo as metodologias de valida&#231;&#227;o distintas usadas nas diferentes culturas, entretanto, ressalta-se que este estudo seguiu a valida&#231;&#227;o proposta pelo estudo de valida&#231;&#227;o do instrumento original.</p></sec><sec><title>Contribui&#231;&#245;es para a &#193;rea</title><p>Este instrumento de avalia&#231;&#227;o da dor poder&#225; ser aplicado no contexto brasileiro, auxiliando os profissionais de sa&#250;de a avaliar a intensidade e gravidade da dor p&#243;s-operat&#243;ria, efeitos colaterais, aspectos f&#237;sicos e emocionais, capacidade funcional e autocuidado dos pacientes ap&#243;s a cirurgia. Sua aplica&#231;&#227;o favorecer&#225; manejo eficaz da dor p&#243;s-operat&#243;ria, assist&#234;ncia de qualidade e seguran&#231;a ao paciente.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUS&#213;ES</title><p>O question&#225;rio <italic toggle="yes">International Pain Outcomes</italic> (IPO) &#8211; vers&#227;o portugu&#234;s do Brasil foi considerado adequado, equivalente ao original quanto &#224; sua adapta&#231;&#227;o cultural, validado para o portugu&#234;s do Brasil e confi&#225;vel para a aplica&#231;&#227;o na assist&#234;ncia a pacientes em p&#243;s-operat&#243;rio. Esse instrumento possibilita o manejo adequado e seguro da dor, contribuindo na preven&#231;&#227;o de complica&#231;&#245;es nesse per&#237;odo.</p></sec></body><back><ack><title>AGRADECIMENTO</title><p>Os autores agradecem ao Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq) pela concess&#227;o da Bolsa de Produtividade em Pesquisa (PQ-307468/2021-6) a Barbosa MH.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>FOMENTO:</bold> Este estudo foi realizado com o apoio da Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior &#8211; Brasil (CAPES) e da Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado de Minas Gerais (FAPEMIG/PPM-APQ-00121-17).</p></fn></fn-group><sec sec-type="data-availability" specific-use="data-in-article"><label>DISPONIBILIDADE DE DADOS E MATERIAL</label><p>Os dados da pesquisa est&#227;o dispon&#237;veis no corpo do artigo.</p></sec></back></sub-article></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>